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ABSTRACT OF THE DISSERTATION
IN VIVO CHARACTERIZATION OF EPILEPTIC TISSUE WITH OPTICAL
SPECTROSCOPY
by
Nitin Yadav
Florida International University, 2012
Miami, Florida
Professor Wei-Chiang Lin, Major Professor
For children with intractable seizures, surgical removal of epileptic foci, if identifiable
and feasible, can be an effective way to reduce or eliminate seizures. The success of this
type of surgery strongly hinges upon the ability to identify and demarcate those epileptic
foci. The ultimate goal of this research project is to develop an effective technology for
detection of unique in vivo pathophysiological characteristics of epileptic cortex and,
subsequently, to use this technology to guide epilepsy surgery intraoperatively. In this
PhD dissertation the feasibility of using optical spectroscopy to identify unique in vivo
pathophysiological characteristics of epileptic cortex was evaluated and proven using the
data collected from children undergoing epilepsy surgery.
In this first in vivo human study, static diffuse reflectance and fluorescence
spectra were measured from the epileptic cortex, defined by intraoperative ECoG, and its
surrounding tissue from pediatric patients undergoing epilepsy surgery. When feasible,
biopsy samples were taken from the investigated sites for the subsequent histological
analysis. Using the histological data as the gold standard, spectral data was analyzed
with statistical tools. The results of the analysis show that static diffuse reflectance
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spectroscopy and its combination with static fluorescence spectroscopy can be used to
effectively differentiate between epileptic cortex with histopathological abnormalities and
normal cortex in vivo with a high degree of accuracy.
To maximize the efficiency of optical spectroscopy in detecting and localizing
epileptic cortex intraoperatively, the static system was upgraded to investigate
histopathological abnormalities deep within the epileptic cortex, as well as to detect
unique temporal pathophysiological characteristics of epileptic cortex. Detection of deep
abnormalities within the epileptic cortex prompted a redesign of the fiberoptic probe. A
mechanical probe holder was also designed and constructed to maintain the probe contact
pressure and contact point during the time dependent measurements. The dynamic diffuse
reflectance spectroscopy system was used to characterize in vivo pediatric epileptic
cortex. The results of the study show that some unique wavelength dependent temporal
characteristics (e.g., multiple horizontal bands in the correlation coefficient map γ(λref =
800 nm, λcomp,t)) can be found in the time dependent recordings of diffuse reflectance
spectra from epileptic cortex defined by ECoG.
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1. Background
1.1. Pediatric Epilepsy and Management
It is estimated by the Epilepsy Foundation that about 45,000 children under the age of 15 may
develop epilepsy each year [1]. One common symptom of epilepsy is seizures, and repeated
seizures are damaging to children because they can cause irreversible injuries to the brain as well
as interfere with the normal brain development [2]. Epilepsy is not a name of a disease; it is
rather a set of common symptoms that arise from different disorders of the brain. According to
the International League Against Epilepsy (ILAE), epilepsy is defined as a chronic condition of
the brain characterized by an enduring propensity to generate epileptic seizures, and by the
neurobiological, cognitive, psychological, and social consequences of this condition. Thus,
epilepsy can be interpreted as a disorder of brain which exists even when there is no seizure.
Epilepsy is a discontinuous process, and it may spontaneously occur at anytime.
Seizures are the most common observable symptom of epilepsy.

Seizures can be

classified as:
1. Partial seizures: They are also called focal or localized seizures. They originate in more
specific locations of the brain and mostly are developed from external injuries.
2. Generalized seizures: They typically occur in both sides of the brain and mostly are
genetic.
Partial seizures are more common than generalized seizures. The cause of a seizure is
determined in about 28% of partial epilepsy patients. In the rest, however, epilepsy is deemed
idiopathic, which means that the cause is unknown [3]. A seizure's effect depends on the location
in the brain. A person can seem to be confused after a seizure or can feel a spasm or, in the
extreme case, may become unconscious.
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While not completely proven, studies have identified various potential causes for epilepsy
including chemical-malfunctioning of ion channels for sodium, potassium and calcium in
neurons and astrocytes [4-7], abnormalities in neurotransmitters like GABA, serotonin and
acetylcholine [5,8-10], or genetic or physical causes like fever, vaccinations, head injuries, viral
infections and brain tumors [11, 12].
1.1.1. Pharmaceutical Therapies
Epilepsy is first treated with antiepileptic medications. Selection of medications is usually
determined by the types of seizures and epilepsy syndromes, since certain medications are more
effective against specific seizure types and syndromes than others. Achieving good control of
seizures with drug treatment generally depends on choosing the right drug, minimizing the
number of drugs prescribed, and educating the patient and family to encourage daily use as
prescribed. Other factors that can affect the choice of drug include potential side effects, the
dosing regimen -- whether it is simple or difficult to follow -- the age of the patient, childbearing
potential, use of other medications, lifestyle, and, in some cases, cost. Whenever possible, using
one drug is preferred. This drug may be prescribed in increasing doses until seizures are
controlled or a side effect occurs. If the drug is not effective or if side effects are hard to live
with, this drug will probably be gradually stopped while another one is slowly introduced.
In general, antiepileptic drugs eliminate seizures for about half of all patients with
epilepsy; for another 20-30%, the intensity and number of seizures is reduced to the point where
the person can live and work normally. The seizures in the remaining 20% of people with
epilepsy do not respond well to current medications, and their condition is termed “refractory to
treatment.” For those patients, other treatment options, such as surgery, vagus nerve stimulation,
or the ketogenic diet, may be explored.
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1.1.2. Dietary Therapy
The diet is based on the observation that starvation, which burns fat for energy and produces
ketones, has an antiepileptic effect. The goal of the diet is to make the body get its energy from
fat and become ketotic. It is primarily done by administering a ketogenic diet to the epilepsy
patients. The ketogenic diet is a high-fat, adequate protein, very low carbohydrate diet that is
both calorie and fluid restricted and initiated in hospital because of risks of severe metabolic
abnormalities during and after the initial fasting period to create and maintain ketosis. Generally,
medications are not discontinued along with ketogenic diet. How ketogenic diet reduces seizures
remains somewhat unclear and is probably multifactorial, but many studies have clearly
demonstrated it effective in >50% reduction of seizures in 38% children [13].
There are also adverse effects associated with ketogenic diet, including sluggishness
during the initial treatment. Staying on ketogenic diet for a long period of time could lead to
kidney stones, high cholesterol, dehydration, constipation, slowed growth or weight gain, and
bone fractures [14]. It should also be noted that certain particular epilepsy syndromes may
respond better to ketogenic diet than others [15].
1.1.3. Vagus nerve stimulation
Vagus nerve stimulation (VNS) is a relatively new procedure in pediatric epilepsy management.
It involves implanting an electronic device in the upper chest that delivers electrical stimulation
to the vagus nerve in the neck to control seizure frequency, severity, and duration. VNS is used
in adjunct treatment with antiepileptic drugs. It has been approved by the US Food and Drug
Administration for use in treating partial seizures in adults and adolescents over age 12 after
medical therapy has failed to control the seizures.
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The VNS therapy system consists of the implantable pulse generator and bipolar VNS
therapy lead, a programming wand with software, a tunneling tool, and a handheld magnet.
Once implanted, the device delivers a regular pattern of stimulation. Patients can turn the device
on if they feel a seizure coming on by using a special magnet, which in some cases may prevent
the seizures. Medical studies of the device suggest that some patients will gain some benefit from
the VNS device although complete seizure control is rare. Approximately one-third of patients
receiving VNS therapy experience at least a 50% reduction in seizure frequency with no adverse
cognitive or systemic effects [16]. Moreover, clinical findings indicate that the effectiveness of
VNS therapy continues to improve over time, independent of changes in AEDs or stimulation
parameters [16]. Tolerance does not appear to be a factor with VNS therapy, even after extended
periods of time. Most people continue to take antiepileptic drugs while receiving the VNS
therapy. The most commonly reported side effects are hoarseness, coughing and breathlessness
[17].
1.2. Epilepsy Surgery
Epilepsy is regarded as refractive if it has been continuously active for 3 years in spite of
adequate trials of therapy with three or more main-line antiepileptic drugs, and if seizures are
frequent (more than one per month). The best way to combat refractive epilepsy is to remove the
epileptic focus and its surroundings.
1.2.1. One Stage Surgery
In one stage surgery, electrocorticography (ECoG) is heavily relied on in the operating room just
before the resection. Here interictal activities of epileptic cortex is captured by ECoG and then
used to define the area of resection. The epileptic cortex defined by ECoG may have consistent
focality in interictal spiking, rhythmic features, trains of focal fast beta activity, or focal
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attenuation of background [18-21]. One stage epilepsy surgery has advantages over the two-stage
one (see below) in terms of cost and less risk of infection. Awake intraoperative ECoG can also
be used to map eloquent cortex [22-24].
1.2.2. Two Stage Surgery
In a two-stage epilepsy surgery, the initial operation aims to place subdural electrodes for seizure
monitoring [16-19]. Ictal zone is then demarcated by seizures occurrence. Sometimes functional
mapping may be performed during the seizure monitoring stage. The information collected
during the monitoring stage will be used to define the zone of resection for the second operation
taking place about one week after the first operation [25]. In planning the resection, a clear
relationship between eloquent cortex and epileptic area needs to be defined [26, 27]. Typically, a
margin of at least 0.5-1 cm is required to spare function. Language cortex can be mapped in
children as young as 2.5 years of age [26, 27]. Two-stage epilepsy surgery is used when the
epileptic zone is discrete, no lesions are present in the imaging study, or the planned resection is
adjacent to eloquent cortex [28]. The main disadvantages of a two-stage surgery are higher costs
and risks of infection [29, 30].
1.3. Technologies Used in the Planning of Epilepsy Surgery
Current technologies used in diagnosis of epilepsy and demarcations of epileptic tissue are:
1.3.1. Electroencephalogram (EEG)
EEG is used to detect abnormal electrical activities in the brain associated with epileptic
seizures. In an EEG study, multiple electrodes are placed on scalp, and the brain wave patterns
are recorded and studied. Through the study, the abnormal patterns that indicate seizures can be
identified. Ideally, EEG should be performed within 24 hours of a seizure. The duration of EEG
recordings vary from an hour to a few days in case of intractable epilepsy.
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An EEG study performed with simultaneous video recording is called a video EEG study
[31, 32]. It provides the doctors insights into the seizure type and the possible brain area where
the epileptic activities originate. Simultaneous video recordings can also provide information to
the determination of paroxysmal event frequency and aid in the diagnosis of nonepileptic
seizures, as well as help with seizure and epilepsy classification [33].
1.3.2. Computerized Tomography (CT) Scans
CT scans take x ray images of the brain from many different angles to determine its
crosssectional configuration with the aid of a computerized reconstruction algorithm. In the
planning procedure of an epilepsy surgery, CT scans may be performed to detect the structural
abnormalities in the brain associated with epileptic seizures [34]. An iodine based dye may be
injected into a patient before taking a CT scan in order to enhance image contrast in certain
anatomical structures such as blood vessels. The amount of radiation used in a CT scanning
procedure is quite low, so it is safe to perform CT scans repeatedly.
1.3.3. Magnetic Resonance Imaging (MRI)
MRI is an imaging modality that uses a magnetic field to change the spin of the atomic particles
in the body and hence perform three-dimensional imaging. The MRI images can be used to
identify abnormal areas in the brain, small brain tumors, blood vessel abnormalities, and changes
in white matter. In the planning stage of an epilepsy surgery, MRI is used to detect the structural
abnormalities in the brain associated with epileptic seizures [35, 36]. MRI is recommended for
children after their first seizure and seizures that are associated with any unexplained significant
mental or motor problems.
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1.3.4. Other Advanced Imaging Techniques
Another popular imaging technology used in the planning stage of an epilepsy surgery is
Positron Emission Tomography (PET). It measures regional metabolic activities in the brain,
based on which brain functions and/or disorders are detected. During a seizure, the area
responsible for the seizure will show up as an area of increased glucose use in the PET images
[37]. Between the seizures, the epileptic focus shows a characteristic pattern of reduced need for
glucose in the PET images [38]. PET has proven to be an important diagnostic tool in selecting
patients with partial epilepsy, in particular with foci in the temporal lobe, for resective surgery
[39]. Single-photon emission computer tomography (SPECT) is another useful technology to
plan an epilepsy surgery. It identifies patterns of change in cerebral blood flow during seizures in
children [40]. It could be useful in clarifying the poorly understood interplay of the interictal and
ictal states in human focal epilepsy [41]. SPECT and PET are generally helpful if MRI is not
much useful for deciding on surgery [42].
Diffusion Tensor Imaging or DTI is used for tracing subtle changes in directionality and
magnitude of water diffusion due to diseases. It enables visualization and characterization of
white matter fascicli in two and three dimensions. It is used to noninvasively assess the
molecular and biochemical environment of cerebral tissue [40, 43]. Diffusion weighted images
can provide information on the molecular movements in the microstructure. DTI can aid in
characterizing and measuring the diffusive transport of water molecules by means of an effective
diffusion tensor, D. The symmetric tensor measurements contains useful information about the
tissue microstructure and architecture [44].
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1.3.5. ECoG
Electrocorticography (ECoG) was first used in 1940 to exactly find the location and extent of the
epileptic brain tissue prior to epileptic surgery. It is now considered as a golden standard for
demarcation of epileptic cortex. ECoG is an invasive procedure which involves placing the
electrodes to monitor electrical activity from cerebral cortex on an exposed brain surface. It can
identify the areas which are epileptic in nature. The recording equipment used for ECoG is same
as that for scalp EEG; a two-dimensional electrode array provides simultaneous recording from
multiple locations. The recording electrodes must make a light contact with the exposed cortex to
generate signals with high signal to noise ratio. Signal filters are set at 0.3–70 Hz and the
sensitivity at 50–75 μV/mm in an ECoG study, otherwise clipping of spikes (often 1–3 mV) and
excessive amplification of other activity could impair data analysis and interpretation. ECoG
provides more valuable information than EEG because it has a high spatial and frequency
resolution and is immune from the eye and muscle artifacts.
Preoperative studies like EEG, CT Scans, and MRI are essential to identify epileptic
activities within the brain that are accessible to resection. Lateralization and at least a rough
localization of the epileptic focus is absolutely necessary to allow correct placement of recording
electrodes. Therefore, the intraoperative ECoG does not replace presurgical evaluation.
Furthermore, it is impossible to use ECoG to distinguish primary epileptiform discharges from
secondary propagated discharges arising at a distant epileptic site [45, 46].
1.4. Optical Technologies for Intraoperative Surgical Guidance
1.4.1. Biomedical Optics
Light traveling in a biological tissue is governed by two tissue optical properties, namely
absorption coefficient µa(λ) [1/cm] and scattering coefficient µs(λ) [1/cm].

8

In the visible

wavelength region (i.e., 400 to 700 nm), the absorption in a biological tissue is caused primarily
by hemoglobin.

Therefore, the absorption coefficient of a biological tissue in the visible

wavelength region may be expressed as
2.303

1

[1/cm]

(1.1)

where [Hb] is the hemoglobin concentration in mole, SatO2 is hemoglobin oxygenation,
the molar extinction coefficient of oxy-hemoglobin [1/cmM], and

is

is the molar extinction

coefficient of hemoglobin [1/cmM]. Because the molar extinction coefficient of hemoglobin
varies significantly in accordance with its oxygenation (see Figure 1.1), it is possible to obtain
the two critical hemodynamic parameters (i.e., [Hb] and SatO2) through the study of µa(λ) of the
biological tissue.
Light scattering inside a biological tissue is a result of spatial variation in tissue
refractive index. Various intra- and extra-cellular components contribute to the light scattering,
and their contributions, in general, are size and density dependent [48, 49]. µs(λ) is defined in
the way that the probability of a scattering event over a short distance s will be µs(λ)×s. µs(λ)
may be correlated with the size/density of scatterers in a biological tissue using Mie theory. That
is
′

1

[1/cm],

(1.2)

where g is unisotropic factor and m = λ × 10 3 . It has been shown that the morphological and
structural characteristics of a biological tissue may be assessed through its µs(λ) [50].
1.4.2.

Optical Spectroscopy

Optical spectroscopy is a technology developed to study the intrinsic properties of a material
through its interaction with light.

Over the past two decades, researchers in the field of

biomedicine have been utilizing optical spectroscopy to perform minimally-invasive, non-
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destructive detections of tissue diseases and injuries in various organs like cervix, brain, skin,
pancreas, colon, breast and esophagus [51-61]. The types of optical spectroscopy frequently used
to perform optical diagnosis include diffuse reflectance spectroscopy and fluorescence
spectroscopy. Diffuse reflectance spectroscopy is used primarily to detect tissue hemodynamics
as well as the compositional and structural information [62]. It has the advantage of being
affordable and portable and producing diagnostic results in real time.

Molar Extinction Coefficient[cm-1/M]
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Figure 1.1: Molar Extinction Coefficients of oxy-hemoglobin (blue) and deoxy hemoglobin (red)
as a function of wavelength [47].
Fluorescence spectroscopy is used to detect and quantify molecules that can absorb a
high energy photon and yield a low energy fluorescence photon (i.e., fluorophores).

In

biological tissues, the endogenous molecules possessing such a capability include: NADH,
FAD2+, Tryptophan and its derivatives (e.g. serotonin, and dopamine) and collagen [63]. In the
research field of optical diagnosis, fluorescence spectroscopy is often used to gauge the redox
state of NADH and hence the metabolic activities of in vivo organs [64].

Accurate

interpretations of fluorescence spectra from in vivo tissue can be very challenging because the
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propagation of both excitation and emission (fluorescence) photons is strongly influenced by the
optical properties of tissue [65].

1.4.3.

Intraoperative Demarcation of Neoplastic and Epileptic Lesions Using Optical

Spectroscopy
The feasibility of using optical spectroscopy to intraoperatively guide cancer surgery has been
evaluated in various cancer types [54, 66, 67]. Several studies have shown that combined
fluorescence and diffuse reflectance spectroscopy can accurately detect brain tumor in vivo and
hence may be used to guide brain tumor resection [51, 68]. A recent study also demonstrates the
potential of using diffuse reflectance spectroscopy alone to detect pediatric brain tumors in vivo
[69]. The concept of using optical spectroscopy to aid epilepsy surgery is very new, and it has
only been explored in a few studies to date [70, 71]. However, a diffuse reflectance imaging
modality (i.e., intrinsic optical imaging) has been used to study the hemodynamic characteristics
of human epileptic cortex in vivo [72, 73]. It should be noted that the intrinsic optical imaging
modality only acquires the diffusely reflected light from the cortex at a few selected
wavelengths. The accuracy of using optical modalities, including fluorescence and diffuse
reflectance spectroscopy, to demarcate epileptic cortex intraoperatively, nevertheless, has not
been proved yet.
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2. Statement of Purpose
2.1. Hypothesis
As discussed in the background section, epilepsy leads to drastic changes in the hemodynamic,
metabolic, and compositional characteristics of the brain tissue, which are tapped by existing
techniques like MRI for seizure localization. Because of the unique advantages provided by
optical spectroscopy, it can potentially play a significant role in the future management of
pediatric patients who have intractable epilepsy and are good candidates for epilepsy surgery.
More specifically, optical spectroscopy may be used to detect unique pathophysiological
characteristics of epileptic cortex in a nondestructive manner in vivo, which, in turn, can assist
surgeons to accurately differentiate an epileptic cortex from a nonepileptic brain during an
epilepsy surgery. The primary objective of this dissertation is to prove this concept, and its
central hypothesis is: fluorescence and diffuse reflectance spectroscopy can detect interictal
pathophysiological characteristics associated with pediatric epileptic cortex in an intraoperative
fashion. To validate this hypothesis, the following specific aims were proposed and carried out.
2.2. Specific Aims
Aim 1: To identify static fluorescence and diffuse reflectance spectral features that differentiate
between normal and epileptic pediatric cortex defined by pathology. The study outcomes related
to this specific aim are presented in chapter 3 of this dissertation.
Aim 2: Develop a portable fiberoptic spectroscopic system with capability to capture dynamic
diffuse reflectance spectra from in vivo brain in an intraoperative environment. The study
outcomes of this specific aim are reported in chapters 4 and 5 of this dissertation.
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Aim 3: Identify dynamic diffuse reflectance spectral features associated with pediatric epileptic
cortex defined by ECoG and pathology. The study outcomes related to this specific aim are
presented in chapter 6 of this dissertation.
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3. In Vivo Characterization of Epileptic Cortex using Static Fluorescence and Diffuse
Reflectance Spectroscopy
3.1. Introduction
According to the Epilepsy Foundation, of the 200,000 new cases of epilepsy diagnosed each year
in the United States, 45,000 are children under the age of 15 [1]. Epilepsy is considered a severe
neurological disorder in children, because its primary symptom, seizure, can severely damage
normal brain development. When the pharmaceutical and/or dietary therapies fail to achieve
seizure freedom, epilepsy is defined as refractory [78, 79]. For pediatric patients with refractive
epilepsy, surgical intervention, when applicable, becomes necessary. Since the success of
epilepsy surgery is determined by the amount of seizure-inducing cortex (i.e., epileptic cortex)
removed, there arises a need to develop some systematic methodology that accurately detect and
demarcates the epileptic cortex pre- and intra-operatively.
Non-invasive diagnostic technologies commonly used in the pre-surgical planning of
epilepsy surgery include electroencephalography (EEG), Video EEG, and several noninvasive
imaging modalities like computed tomography (CT), single-photon emission computed
tomography (SPECT), magnetic resonance imaging (MRI), positron emission tomography
(PET), and diffusion tensor imaging (DTI) [80-84]. Advancements in noninvasive imaging
modalities over the past two decades have greatly improved their ability to identify epileptic
cortex or lesions and, hence, surgical outcomes [80, 83, 84]. However, the above mentioned
diagnostic technologies, when used individually, cannot provide definitive information upon
which surgery can be based; they, at best, provide approximate locations of seizure origins due to
their limited sensitivity and spatial resolution [80, 83, 45]. In addition, these technologies may be
difficult to use on pediatric patients who may not be able to remain motionless for extended
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periods of time [85]. Finally, spatial coordinates of the epileptic cortex defined in these studies
may lose their value because of brain shift/deformation during the craniotomy procedure [86-89].
When EEG/imaging studies are inconclusive, electrocorticography (ECoG) may be used
to perform invasive mapping of the ictal onset zone [45, 90]. In addition, ECoG is used in the
operating room to directly detect interictal epileptiform discharges from the abnormal brain
region, which are used to define the resection margins for the surgeon. However, ECoG may
detect interictal discharges in normal brain as well, as a result of electrical spreading, and
epileptic focus localization using interictal discharges is subject to a certain amount of
uncertainty in anesthetized brain [90]. Histological evaluation of epileptic cortex has uncovered
many unique pathological features such as balloon cells and cortical dislamination [91]. This
information usually is acquired through post-operational histopathological analysis of the
resected brain specimens and is not immediately available in the operating room. While
histopathological features of the lesion may not correlate with surgical outcomes [83, 19], it is
not yet clear if their presence can be used as an objective indicator with which to demarcate the
area of epileptic brain. The technological shortcomings and limitations described above
frequently lead to incomplete removal of epileptic lesions, which adversely affects surgical
outcomes. This is especially true for cases of extra-temporal epilepsy, which is common in
children [80, 84, 85, 19]. For these reasons, new technologies for intraoperative identification
and demarcation of the epileptic brain area are needed to enhance the prognosis of epilepsy
surgery for patients with intractable non-lesional extra-temporal epilepsy. These new
technologies, ideally, should be developed in accordance with the intrinsic characteristics of
epileptic brain during the interictal period.
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Because the intrinsic compositional and structural characteristics of tissue strongly affect
its absorption and scattering properties, it is feasible to use the interaction between light and
biological tissue to estimate these qualities and, hence, detect whatever alterations that result
from disease development [51, 56, 74, 92-99]. Such an optic-based diagnostic technology often
is termed optical diagnosis; its advantages include its low cost, portability, and real-time
application. Among the existing optical diagnostic methodologies, many are based on
fluorescence and diffuse reflectance spectroscopy. This is because several intrinsic biological
chromophores (e.g., hemoglobin) and fluorophores (NADH) can be used to assess critical
intrinsic physiological characteristics of biological tissue, including its hemodynamics and
metabolism [98, 99 64, 100, 101].

The feasibility of using optical spectroscopy to intra-

operatively guide cancer surgery has been evaluated for various cancer types. Several studies
have shown that combined fluorescence and/or diffuse reflectance spectroscopy can accurately
detect brain tumors in vivo and, hence, may be used to guide brain tumor resection [51, 69].
However, applying optical spectroscopy to the detection of epileptic cortex has only been
explored in a limited fashion to date [70-72, 101, 102].
In this chapter, combined fluorescence and diffuse reflectance spectroscopy was used to
detect unique pathophysiological and morphological characteristics of epileptic cortex in an in
vivo human study. Static diffuse reflectance and fluorescence spectra were acquired from in vivo
epileptic and normal cortex of pediatric patients undergoing epilepsy surgery. Spectral data were
analyzed using various statistical tools, and unique spectral features associated with epileptic
brain tissue defined by histology and ECoG were identified. The physiological underlying
mechanisms responsible for these spectral alterations were extrapolated.
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3.2. Materials and Methods
3.2.1. Instrumentation
For this study, a portable spectroscopy system was used for acquiring fluorescence and diffuse
reflectance spectra from the brain. The system consisted of two light sources: a pulsed nitrogen
laser (VSL-337; Spectra Physics) for fluorescence spectroscopy and a portable halogen lamp
(LS-1; Ocean Optics) for diffuse reflectance spectroscopy. Since data collection was performed
in a sterile field, a sterilizable fiberoptic probe was used in conjunction with the spectroscopy
system. The probe consisted of seven 300-micron core optical fibers, out of which two were used
to conduct excitation light and the remaining fibers for reflected light collection. Based on the
arrangement of the optical fibers in the probe, its volume of investigation was estimated at
roughly 1 mm3. The collection fibers of the optical probe were connected to a spectrometer (USB
2000-FL Spectrometer; Ocean Optics) with a spectral range of approximately 300-900 nm. The
spectrometer was connected to a computer via a universal serial interface. A computer program
was developed using LabView from National Instruments to control the entire spectral
acquisition procedure.
3.2.2. Study Procedure
Static fluorescence and diffuse reflectance spectra were acquired from normal and epileptic brain
areas, as defined via pre-operative imaging and ECoG studies, in pediatric patients undergoing
epilepsy surgery. From each single patient, five or more measurement sites were selected at the
exposed brain surface by the surgeon. These sites usually were equally distributed within and
outside the resection zone. Prior to the spectral acquisition procedure, the investigated site was
cleansed using saline to remove any residual blood on its surface. The optical probe was placed
in direct contact with the cortical surface without deforming the brain surface, and three spectra
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(i.e., baseline, fluorescence, and diffuse reflectance spectra) were acquired sequentially. Spectral
acquisition was repeated three times, with the total time required to complete the abovementioned procedure less than 15 seconds. The locations of the optically-investigated sites and
their spatial correlation with the ECoG electrode grids were documented using a digital camera.
Biopsies were taken from the investigated sites within the zone of resection and stored in a 10%
buffered formalin solution for subsequent histological analysis.
3.2.3. Histological Evaluation
All specimens collected in this study were processed in a histology lab. They were embedded in
paraffin wax and then sectioned. From each specimen, three to four 4-micron thick sections were
cut and stained using the conventional hematoxylin and eosin staining method. The prepared
section was evaluated by a neuropathologist at the University of California, Los Angeles (Dr.
Rupal Mehta). These tissue sections were assessed for architectural laminar disorder,
cytomegaly, dysmorphism, and balloon cell change. These findings were graded from 0-3 (0none, 1-mild, 2-moderate and 3-severe). The presence of binucleated cells and calcification was
also noted separately. These morphological characteristics then were used to categorize spectral
data as either normal or histologically abnormal.
3.2.4. Data Processing
All spectral data acquired from the in vivo study were preprocessed to remove any artifacts
induced by instrumentation. Mainly, baseline subtraction and calibration applications were
performed to all acquired fluorescence spectra F (λ ) and diffuse reflectance spectra Rd (λ ) [68].
Furthermore, to speed up the data analysis procedure, spectral range and resolution were further
reduced. Specifically, diffuse reflectance data between 400 nm and 850 nm and fluorescence
data between 380 nm and 750 nm were preserved; spectral resolution was reduced to 5 nm. In
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addition to the individual spectral types, a combined spectrum was created for the data analysis
process, specifically the ratio of the fluorescence and diffuse reflectance spectra (i.e.,
F (λ ) / Rd (λ ) ). The wavelength range of the combined spectra was 400 to 750 nm, and their

resolution was 5 nm. Several normalization techniques were applied to the preprocessed spectra,
including local maximum normalization, area under the curve normalization, global mean
normalization, and arbitrary reference normalization (See Figure 3.1). For local maximum
normalization,

each

spectrum

is

normalized

to

its

maximum

value.

That

is

S max (λ ) = S (λ ) / MAX ( S (λ )) , where S (λ ) represents either F (λ ) , Rd (λ ) , or F (λ ) / Rd (λ ) , and
MAX is the maximum operation. For area-under-the-curve normalization, the new spectrum
S AREA (λ ) is calculated by S AREA (λ ) = S (λ ) /  S (λ ) . For global mean normalization, each spectrum
λ

is normalized to the mean of the total spectral data set. That is S MEAN (λ ) = S (λ ) /[  n S (λ ) / n] ,
where n represents the number of spectra in a single spectral dataset. Finally, arbitrary reference
normalization produces a new spectrum using S POINT (λ ) = S (λ ) / S (λref ) , where λ ref is an
arbitrary reference wavelength.
3.2.5. Data Analysis and Classification Algorithm Development
The main objective of this analysis was to determine if in vivo fluorescence and diffuse
reflectance spectroscopy can detect histopathological and/or pathophysiological characteristics
that are unique to epileptic brain tissue. To achieve this goal, the spectral data collected were
classified using the results of histological analysis: the normal brain data containing spectral data
measured from brain tissue outside the zone of resection, and the epileptic brain data containing
spectral data from epileptic brain tissue confirmed by both histology and ECoG. To identify
spectral regions and unique spectral features distinguishing epileptic brain tissue from normal
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cortex, mean comparisons of the processed spectra from the two types of brain tissue (normal vs.
epileptic) was performed for all wavelengths. Depending on the distribution and variance
characteristics of the data, either parametric (i.e., Student’s t-test) or non-parametric tests
(Wilcoxon Rank Sum test) were employed for mean comparisons. Next, tissue classification
algorithms were developed based on linear discrimination analysis (LDA), for the purpose of
determining the accuracy of using optical spectroscopy to differentiate between normal and
epileptic brain tissue. LDA inputs were the spectral data from normal and epileptic brain.

Figure 3.1: The flow chart of the data processing procedure employed in the study.
Spectral data at all wavelengths were used in this process to create a model of
discrimination, and standardized canonical coefficients used to assess the importance of spectral
data region in determining tissue type. It was important to ensure that the discrimination model
was statistically significant in terms of distinguishing normal brain from epileptic brain;
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therefore, only models associated with chi-square p values less than 0.05 were considered.
Furthermore, only models with sensitivity and specificity greater than 75% were considered
‘successful’ and reported here. Finally, tissue type classification was validated using the cross
validation method (i.e., building the model based on all data but one variable, and predicting the
one excluded variable).
3.3. Results
In this study, a total of 16 patients were enrolled, for whom demographic information is
summarized in Table 3.1. The total number of useful investigated sites from these patients was
84, among which 28 sites were located outside the resection zone defined by ECoG (i.e., normal
brain) and 56 sites within the zone of resection (ZOR). The 56 sites within the ZOR were further
divide into two subcategories in accordance with the results of histological evaluation: 30 sites
exhibited histological features associated with epilepsy (epileptic brain), while the remaining 26
sites did not. The distribution of sites is shown in Table 3.2.
Spectral data analysis revealed that only those spectral differences identified within four spectral
types (i.e., original Rd (λ ) , Rd MEAN (λ ) , Rd POINT (λ ) , and F / Rd MEAN (λ ) ) could produce
discrimination algorithms with sensitivity and specificity greater than 75%. Analytical results for
each spectral type follow.
3.3.1. Original Rd (λ )
Comparing the original Rd (λ ) from normal and epileptic brain revealed significantly different
mean Rd (λ ) intensity between 400 and 600 nm (p < 0.05, see Figure 3.2). Inputting the Rd
signals from this spectral band, the best classification result based on LDA was 82.1%
sensitivity, 76.7% specificity, and 79.3% total accuracy.
3.3.2. Rd MEAN (λ )
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Similar to original Rd (λ ) , Rd MEAN (λ ) between 400 and 600 nm also was statistically different
between normal and epileptic brain (p < 0.05, see Figure 3.3). Entering the signals from this
spectral band, the best classification result based on LDA was 75.0% sensitivity, 83.3%
specificity, and 79.3% overall accuracy, which is comparable to using the original Rd (λ ) .
Patient Age/Gender
Patient Number
1
3/M
2
4/F
3
4/M
4
6/M
5
2/F
6
14/F
7
8/F
8
21/F
9
2/M
10
20/F
11
17/F
12
5/M
13
3/F
14
16/F
15
10/M
16
3/M
Table 3.1: Demographic information of the patients studied.

ECoG Pathology Site #
-

NA

28

+

-

26

+

+

30

Table 3.2: Distribution of the investigated sites.
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3.3.3. Rd (λ ) / Rd (λref )
Analyzing Rd (λ ) / Rd (λref ) , as shown in Figures 3.4 and 3.5, revealed several spectral features
that could effectively differentiate normal from epileptic brain. Most of these spectral features
were evident between λref = 400 and λref = 600 nm. Entering these identified spectral features,
classification results based on LDA were ~75% sensitivity and ~80% specificity (Table 3.2).
Discrimination was optimized when λref was 505 nm, where the overall accuracy of the
discrimination algorithm was 86.2%.
3.3.4. [ F (λ ) / Rd (λ )] /[ F (λref ) / Rd (λref )]
Analysis of [ F (λ ) / Rd (λ )] /[ F (λref ) / Rd (λref )] , as shown in Figures 3.6 and 3.7, also revealed
several spectral features from the combined spectrum that could effectively distinguish normal
from epileptic cortex. Again, the majority of these spectral features were located between λref =
400 and λref = 600 nm. Entering the identified spectral features, classification results based on
LDA yielded sensitivity above 75% and specificity above 80% (Table 3.3). Discrimination was
optimized when λref was 485 nm, where the overall accuracy of the discrimination algorithm was
96.6%.
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(a)

(c)
Sensitivity: 82.1%
Specificity: 76.7%
Total Correct
Classification: 79.3%

(b)

Figure 3.2: (a) The black solid line represents the mean original Rd(λ) from the normal brain
group, and the solid pink line the epileptic brain group. The error bars represent one standard
deviation of the mean. p value is below 0.05 between 400 and 600 nm. (b) Statistical meancomparison of original Rd(λ) between normal and epileptic brain. (c) The optimal performance
of the classification based on LDA, using original Rd(λ) as the inputs, was sensitivity = 82.1%,
specificity = 76.7%, and total correct classification = 79.3%.
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(a)

(c)
Sensitivity: 75%
Specificity: 83.3%
Total Correct
Classification: 79.3%

(b)

Figure 3.3: (a) The black solid line represents the mean RdMEAN(λ) from the normal brain group,
and the solid pink line the epileptic brain group. The error bars represent one standard
deviation of the mean. p value is below 0.05 between 400 and 600 nm. (b) Statistical meancomparison of RdMEAN(λ) between normal and epileptic brain. (c) The optimal performance of
the classification based on LDA, using RdMEAN(λ) as the inputs was sensitivity = 75%, specificity
= 83.3%, and total correct classification = 79.3%.
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Figure 3.4: (a) Surface plot of the p_values from the mean-comparison of Rd(λ)/Rd(λref) between
normal and epileptic brain. (b) Representative test results with reference wavelength λref = 505
nm. The blue solid line represents the mean Rd(λ)/Rd(λref) of the normal brain group, and the
blue dash line the epileptic brain group. Statistically significant differences (p < 0.05) are found
between 425 nm and 460 nm and 535 nm and 575 nm in this case.
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850

0.05

800
0.04
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750
700

0.03

650
600

0.02

550
500

0.01

450
400
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500
600
700
800
Reference Wavelength (nm)

Figure 3.5: Surface plot of the p-values from the mean comparison of Rd(λ)/Rd(λref) from the
normal and the epileptic cortex group. Each data column in this surface plot represents the lineplot shown in Figure 3.4.
λref (nm) Sensitivity (%) Specificity (%) Total Correct Classification (%)
445
75
86.7
81
455
75
80
77.6
460
75
83.3
79.3
500
78.6
90
84.5
505
82.2
90
86.2
535
78.6
86.7
82.8
550
78.6
86.7
82.8
605
78.6
86.7
82.8
Table 3.3: Classification results of the discrimination algorithms based on LDA using
Rd(λ)/Rd(λref) as the inputs.
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Figure 3.6: Representative statistical mean comparison of [F(λ)/Rd(λ)]/[F(λref)/Rd(λref)] from the
normal and epileptic groups. Here λref is 485 nm. The blue solid line represents the mean
spectrum of the normal group, and the blue dash line the epileptic group. The statistically
significant differences (p < 0.05) are found between 430 nm - 450 nm as well as 625 nm - 660
nm.
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Figure 3.7: Surface plot of p values from the mean comparison of [F(λ)/Rd(λ)]/[F(λref)/Rd(λref)]
from normal cortex and epileptic cortex. Each data column in this surface plot represents the
line-plot shown in Figure 3.6.
Total Correct
Classification (%)
400
75.0
83.3
79.3
420
75.0
86.7
81.0
455
89.3
86.7
87.9
485
92.9
100.0
96.6
500
85.7
90.0
87.9
505
89.3
90.0
89.7
510
89.3
90.0
89.7
520
92.9
90.0
91.4
Table 3.4: Classification results of the discrimination algorithms based on LDA, using
[F(λ)/Rd(λ)]/[F(λref)/Rd(λref)] as the inputs.
λref (nm)

Sensitivity (%) Specificity (%)
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3.4. Discussion
The in vivo study results reported in this chapter demonstrate that in vivo static diffuse
reflectance spectroscopy, as well as its combination with static fluorescence spectroscopy, can be
used to effectively differentiate epileptic brain (as defined by ECoG and histology) from normal
brain with a high degree of accuracy. The most effective discrimination algorithm is derived
using the spectral features from [ F (λ ) / Rd (λ )] /[ F (485nm / Rd (485nm)] , where discrimination
accuracy reaches 96.6%. This supports the concept of developing a new intraoperative guidance
system based on optical spectroscopy, to detect histopathological abnormalities associated with
epileptic brain in the operating room and, thereby, provide additional information to aid in the
demarcation of epileptic foci.
Using parametric and non-parametric statistical comparison methods, original Rd (λ ) ,
Rd MEAN (λ ) , and Rd (λ ) / Rd (λref ) between 400 and 600 nm were found to be significantly
different in epileptic versus normal brain. Since diffuse reflectance spectra in this region are
heavily influenced by hemoglobin absorption, this finding implies that certain static
hemodynamic characteristics of epileptic cortex, in particular hemoglobin concentration and
hemoglobin oxygenation, are very different from that of normal cortex. Previous studies have
shown that hypometabolism and hypoperfusion are frequently observed in the area of an
epileptic focus and its immediate surroundings in the brain of patients with partial seizures [104109]. In addition, Stefanovic et al pointed out that normal interictal neurovascular coupling is
progressively compromised by sustained seizure attacks [109]; Schwartz suggested that epileptic
cortex generally receives inadequate cerebral blood flow [75]. However, alterations in resting
state hemodynamics may not exist in all types of refractive epilepsy. It has been shown that
average resting metabolism and blood flow are largely unremarkable in patients with idiopathic
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generalized epilepsy [110-112]. Because of significant differences in the discharge
characteristics of ictal versus interictal states, it has been suggested that the cerebral blood flow
and cerebral metabolic rate of oxygen changes induced by interictal discharges may be far less
noticeable than their ictal counterpart [104, 111, 113]. This implies that the changes in diffuse
reflectance signals reported here are not necessarily associated with the presence of interictal
discharges. The results of this study further suggest that histological abnormalities may be linked
to changes in regional resting state hemodynamics. It is possible that histological abnormalities
like cortical dysplasia modify the characteristics of astrocytic Ca2+ oscillations, which, in turn,
alter astrocytic function regulating cerebral blood vessel diameters and, hence, regional
hemodynamics [114-118]. More studies, however, will have to be conducted to verify such
conjectures.
When illuminated by an excitation light at 337 nm, the intrinsic fluorescence signal
collected from brain tissue between 450 nm and 500 nm emission is believed to originate
primarily from NAD(P)H. This assumption is based upon two factors: (1) NAD(P)H has a
relatively high quantum yield relative to other biological fluorophores at the same excitation
wavelength; and (2) the concentration of NAD(P)H is very high in the brain, due to brain’s high
metabolism. Several studies have shown that the metabolic activities of any in vivo biological
tissue, including brain, may be monitored through NAD(P)H fluorescence [74, 99]. Since
epileptic cortex is hypo-metabolic [104-109], it has been hypothesized that fluorescence
spectroscopy may be used to detect this characteristic of epileptic brain. However, the study
results reported here do not support this hypothesis; the intrinsic fluorescence spectra (337 nm
excitation) from epileptic brain were not significantly different from those of normal brain. One
possible explanation for this inefficiency is that fluorescence signals measured from in vivo brain
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are heavily modulated by its absorption (i.e., hemoglobin concentration and hemoglobin
oxygenation) as well as scattering properties. In order to truly verify the usefulness of NADH
fluorescence at detecting epileptic cortex, intrinsic fluorescence quantity must be retrieved using
complex spectral processing techniques [76].
The results of the current study are promising, but only preliminary in nature. Several
obstacles must be overcome before the clinical value of optical spectroscopy, namely
fluorescence and diffuse reflectance spectroscopy, is clarified for demarcating epileptic foci and,
hence, aiding epilepsy surgery. The most important challenge is the lack of a gold standard for
defining epileptic brain. While optical spectroscopy can indirectly detect histological
abnormalities of epileptic brain, it is not yet proven that these histological features provide better
demarcation than ECoG. Furthermore, this study also revealed considerable discrepancies
between the results of ECoG and those of histological study. On many occasions, the brain area
classified as abnormal by ECoG was interpreted as histologically normal by our
neuropathologist. This may be attributed to the fact that the optical probe we used in this study
has a limited depth of investigation (less than 1 mm). Therefore, optical investigation was
performed only on the superficial layer of the cortical surface; histopathological abnormalities
present in the deeper layers of the cortex could be missed by either optical spectroscopy or
biopsy. Another possible explanation is that conventional histological methods cannot detect
molecular alterations underlying the abnormal electrical activities of epileptic cortex. Also, it is
possible that the origin of interictal spikes may not be the same as that defined by ECoG due to
electrical spreading. Finally, it will be challenging to establish a universal normal baseline for the
diffuse reflectance and fluorescence spectra of normal pediatric cortex, because the brain
undergoes development and increases in size and weight significantly throughout childhood. To
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address the challenges mentioned above, a new probe should be engineered to investigate various
layers of cortex for abnormalities associated with epilepsy. Moreover, a dynamic spectroscopy
system that is capable of continuously recording fluorescence and diffuse reflectance spectra
from the in vivo brain at a high rate (> 15 Hz) should be developed and used. Such a system will
allow us to gain insights into the dynamic natures of epileptic cortex during the interictal state,
which could yield a better spectral discriminant. These new developments will be reported in the
following chapters.
3.5. Conclusions
The feasibility of using diffuse reflectance and fluorescence spectroscopy to aid epilepsy surgery
in children was investigated. Static diffuse reflectance and fluorescence data were collected from
abnormal cortex, as defined by pathology and ECoG. Tissue discrimination algorithms with high
sensitivity and specificity were produced using various spectral features. The success of this
study warrants a future large-scale study to verify the potential role of optical spectroscopy in
pediatric epilepsy surgery.
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4. Design and Develop a Portable Dynamic Spectroscopy System for In Vivo Epileptic
Brain Study
4.1. Introduction
Fiberoptic spectroscopy systems are commonly used in optical diagnostic studies [119, 120].
However, they often are used to capture the static natures of in vivo tissue. Since the brain is a
dynamic organ and the epileptic brain processes several unique temporal physiological
characteristics, it is important to improve the optical spectroscopy system described in chapter 3
to capture these unique features and hence, maximize the efficiency of optical spectroscopy in
detecting epileptic cortex intraoperatively.

In this chapter, details about the design and

development of a new dynamic spectroscopic system for in vivo study of the epileptic brain are
presented.
4.2. Optical Probe Design and Development
One major task of the instrumentation update was to optimize the design of the optical probe.
The arrangement of the optical fibers within an optical probe influences the collection efficiency
of reflected light (i.e., signal to noise ratio) and, more importantly, the volume and the depth of
investigation. As mentioned before, histopathological studies of epileptic cortex have shown that
structural abnormalities associated with epilepsy may exist in the deeper layers (2 to 4 mm) of
the cortex. Therefore, it is critically important to understand the design parameters of the fiber
optical probe, mainly the distance between the source fiber and the collection fiber (i.e., sourcedetector separation), influence the depth of investigation and signal to noise ratio. To gain this
insight, a computer simulation model for photon migration, Monte Carlo simulation, was
developed and used.
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4.2.1. Materials & Methods
Monte Carlo simulation for photon migration is a popular tool to study light propagation and
distribution in biological tissues (i.e., scattering-absorbing media). The mathematical algorithms
of the MC simulation can be found elsewhere [121]. To speed up the development process, the
new simulation code was developed using a MC simulation model previously developed by Dr.
Wei-Chiang Lin (WCLMC). WCLMC was derived from the source codes written by Dr. Andy
Dunn, University of Texas at Austin, as well as those written by Dr. Steve Jacques and Lihong
Wang at MD Anderson Cancer Center. WCLMC simulates the steady state photon distribution
within and outside a multilayered tissue slab (i.e., diffuse reflectance, fluence rate, and diffuse
transmittance), illuminated by a light source at an arbitrary incident angle.
In order to adapt WCLMC for the needs of the probe design study, the following modifications
were performed.
(I)

The location and the diameter of the detection fiber can be specified by the user.
When a photon package is launched by the source fiber (centered at the origin), its
trajectory within the simulated tissue will be recorded and preserved, if its exit
location is within the area of detection determined by the detection fiber.

(II)

The collection of reemitted photons is exit angle dependent. This modification takes
the finite numerical aperture of an optical fiber into consideration. Also, it provides
the capability of designing an optical probe with tilted optical fibers, which can
control the depth of investigation in an optical diagnosis application [122, 123].

(III)

The weight deposition (i.e., energy absorption) by a photon package, while it is
traveling within the simulated tissue, is registered (see Figure 4.1). In this simulation
model, weighted photon (i.e., photon package) is used and its initial weight is 1.
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(IV)

The weight deposition is registered 3-dimensionally. The tissue slab was divided into
an array of voxels whose dimensions (i.e., dx, dy, and dz) are defined by the user.
This setup facilitated layer wise summation of photon weight deposition, which, in
turn, provides knowledge about the contributions of individual layers to the detected
signal (see Figure 4.2).

The modified WCLMC was called ProbeMC, and its flow chart is depicted in Figure 4.3.
Since brain cortex has a layer wise structure [124, 125], ProbeMC was designed to handle such a
characteristic. Specifically, the simulated tissue in ProbeMC may have an arbitrary number of
layers; each layer is homogenous and has a unique thickness and optical properties. The width
of the simulated tissue is infinite in general. Optical properties of each layer used in the
simulations for the probe design study were those from human gray and white matter (see Table
4.1) [126-129]. An example input file of ProbeMC is provided in Table 4.2. Finally the number
of photons used in each simulation was sufficiently large (e.g., 10 million) to smooth out the
statistical noises associated with the MC simulation. ProbeMC was computationally intensive;
therefore, several multi-core personal computers were used to complete the simulation work
needed to complete the probe design study. The simulation results were displayed in 3D using
Voxler software from Scientific Software Group. The accuracy of ProbeMC was confirmed by
comparing its results with those produced by WCLMC using identical input parameters.
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(a)

(b)

Figure 4.1: (a) A 2-D illustration of multiple photon trajectories within the simulated tissue.
The symbols represent the locations of photon energy deposition. (b) Weightwise display of a
photon package migrating from the source fiber to the detector fiber. Here white color denotes
the weight of the photon package is 1; black is 0.
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Figure 4.2: Illustration of an example grid cell (voxel) centres used to record photon weight
deposition in ProbeMC.
850 nm
Thickness (cm)
mua (cm-1)
mus (cm-1)
g
Layer 1
0.4
0.47
67
Layer 2
1.6
1
342
-1
-1
450 nm
Thickness (cm)
mua (cm )
mus (cm )
g
Layer 1
0.4
0.7
117
Layer 2
1.6
1.4
420
Table 4.1: Optical properties of the simulated brain tissue at 450 nm and 850 nm.
represents the cortex and Layer 2 the white matter.
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0.9
0.88
0.88
0.78
Here Layer 1

Input Parameters:
Source radius, Detector radius, Detector location,
Properties of tissue, Exit angle and No of photons

Launch photons

Generate step size

Absorption, Scattering,
increment pathlength
by step size

No

Hit detector
surface
Yes
Store in an array:
Photon Trajectory,
Weight Loss,
Exit Angle

End
Figure 4.3: Flowchart of ProbeMC developed in house for the probe design study.
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Number of Layer
Refractive index of the incident medium
mus
mua
g
Thickness
Refractive index
Refractive index of the back medium
Number of photons
Number of x grids
dx
Number of y grids
dy
Number of z grids
dz
beam radius (cm)
X coordinate of detector
Y coordinate of detector
Detector Radius
Table 4.2: Representative input file for ProbeMC.
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2
1
Layer 1
See Table 4.1

0.4
1.4
1
10,000000
1
4
1
4
20
0.1
0.015
0.090
0
0.015

Layer 2

1.6
1.4

4.2.2. Results
4.2.2.1. Signal Strength vs. Source Detector Separation
Figure 4.4 shows the simulated relationship between the diffuse reflectance intensity and the
source detector separation (S-D), using the brain model depicted in Table 4.1. Clearly diffuse
reflectance decreases quickly when S-D increases; the rate of decrease with S-D < 1 mm is much
greater than that with S-D > 1 mm. Comparing the relationships at 450 nm and 850 nm, it was
noticed that the rate of decrease in diffuse reflectance intensity is slower at 850 nm than that at
450 nm. This indicates that the S/N ratio of the diffuse reflectance signal at 450 nm will suffer
more significantly than that at 850 nm when S-D increases.
1.00E+02
850 nm

Intensity (W/cm2)

1.00E+01

450 nm

1.00E+00
1.00E-01
1.00E-02
1.00E-03
1.00E-04
1.00E-05
0.00E+00

5.00E-01
1.00E+00
S-D Separation (cm)

1.50E+00

Figure 4.4: Diffuse reflectance intensity (W/cm2) at 450 nm and 850 nm as a function of sourcedetector separation (S-D).
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4.2.2.2. Weight Deposition vs. Source Detector Separation
Figure 4.5 depicts the relationship between the layerwise photon weight deposition and source
detector distance at 450 nm. Here, the majority of the photon weight deposition takes place
within the first layer (i.e., 0 to 0.1 cm). In other words, the first 0.1 cm of the simulated tissue
sample dictates the magnitude of the diffuse reflectance signal at 450 nm. As the source detector
separation increases, the percentage weight deposition in layer 2 increases steadily (i.e., making
a stronger influence to the signal detected). However, the effect of SD on the weight deposition
in layers 3 and beyond is minimal. Therefore, diffuse reflectance signals at 450 nm will not be
sensitive to the optical characteristics of the cortex beyond 2 mm below the surface.
Figure 4.6 depicts the relationship between the layerwise photon weight deposition and S-D at
850 nm. The majority of the photon weight deposition takes place within the first five layers
(i.e., 0 to 0.5 cm) of the simulated tissue. In other words, the first 5 mm of the tissue sample
strongly dictates the magnitude of the diffuse reflectance signal at 850 nm. As S-D increases, the
relative weight deposition in layers 2 to 5 increases steadily (i.e., making a stronger influence to
the signal detected).
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Figure 4.5a: Photon weight deposited in the individual layer as a function of S-D. Each line
represents a unique S-D (specified in the legend). Optical properties at 450 nm were used in this
set of simulations.
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Figure 4.5b: Percentage contribution of individual layer to the overall weight deposition (i.e.,
the reduction in the detected diffuse reflectance signal) as a function of S-D. Each line
represents a unique S-D (specified in the legend). Optical properties at 450 nm were used in this
set of simulations.
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Figure 4.6a: Photon weight deposited in the individual layer as a function of S-D. Each line
represents a unique S-D (specified in the legend). Optical properties at 850 nm were used in this
set of simulations.
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Figure 4.6b: Percentage contribution of individual layer to the overall weight deposition (i.e.,
the reduction in the detected diffuse reflectance signal) as a function of S-D. Each line
represents a unique S-D (specified in the legend). Optical properties at 850 nm were used in this
set of simulations.

46

4.2.3. Conclusions
As mentioned earlier, the histopathological features of epileptic cortex could be present at all
layers of the cortex. Therefore, it is important to design an optical probe that can investigate the
abnormality 4 mm beyond the cortical surface. According to the simulation results presented in
the previous section, the depth of the investigation can be easily controlled by modifying the
source-detector separation. Because of the highly absorbing and scattering nature of the cortex
in the shorter wavelength region (i.e., < 600 nm), it is difficult to investigate deep tissue
abnormality using diffuse reflectance signals in this wavelength band, regardless of what the
source-detector separation is. In this longer wavelength region (i.e., > 600 nm), the efficiency of
using diffuse reflectance signal to investigate the deep cortical abnormalities increases as the
source detector separation increases. However the trade-off of increasing the source detector
separation is the signal to noise level (S/N) is going to decrease significantly (see Figure 4.4).
To meet the needs of high S/N as well as deep tissue investigation, it is important to keep the
source-detector separation greater than 600 µm but smaller than 1000 µm, and the illumination
should be beyond 600 nm.

47

4.3. Dynamic Spectroscopy System Design and Development
4.3.1. Introduction
The spectroscopic system used in the in vivo brain studies (see Chapter 3) was designed to
capture the static nature of the investigated tissue. The existing knowledge about pediatric
epileptic cortex leads one to believe that a wealth of diagnostic information about epileptic
cortex may be found in the temporal variations of their intrinsic characteristics such as
metabolism and hemodynamics. Therefore, it was the goal of this study to convert the existing
static spectroscopy system (i.e., F(λ) and Rd(λ)) into a dynamic one (i.e., F(λ,t) and Rd(λ,t)). In
order to perform time dependent measurements, it was instrumental to have a stable light source
that provides stable excitation light. Due to its pulsed nature and limited repetition rate (i.e., 20
Hz), the nitrogen laser was deemed not suitable for the time dependent fluorescence
spectroscopy study. The ideal replacement for the nitrogen laser would be CW UV lasers, but
they are priced beyond the budget of the project. Therefore, the upgrade of the system only
focused on the diffuse reflectance spectroscopy part.

To achieve this goal, the following

upgrades were planned:
(1) A sensitive spectrometer should be used to reduce the time required to acquire a
single spectrum (i.e., integration time). Here the target integration time was 30 ms,
which would yield a 33 Hz spectral acquisition rate matching with the frequency band of
alpha waves.
(2) A powerful broadband light source with a high temporal stability should be used. The
output power of the light source should be high enough to maintain the S/N of the
acquired spectra above 20 and, at the same time, low enough not to induce thermal
damage to the tissue.
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(3) A fast controller with a larger memory capacity (i.e., more RAM) should be used to
reduce the time required to write the spectral data to the hard drive during an acquisition
procedure. The memory should be sufficiently large in order to allow continuous spectral
acquisition for at least 12 seconds (i.e., 400 spectra) per investigation.
4.3.2. Materials and Methods
In order to perform the continuous diffuse reflectance spectral acquisition, the controller
software was modified first. The modification allowed users to specify (1) the spectral
acquisition rate (# of spectra per second), (2) the recording duration (total # of spectra acquired),
and (3) the integration time for each spectral acquisition. To reduce the overhead resulting from
directly writing the spectral data to the hard drive of the controller, the acquired spectra were
stored in the RAM (4 GB) first and then saved to the hard drive upon completion of a single
investigation.
To determine the applicability of the existing components in the static spectroscopy
system for the time dependent spectroscopy measurements, the following studies were designed
and carried out.
1. Quantify the noise level and characterize the noise characteristics ns(λ,t) of the existing
spectrometer (USB2000, OceanOptics). The main purpose of this sub-study was to determine
the magnitude and the frequency spectral composition of the spectrometer noise. The static
spectroscopy system was used to acquire diffuse reflectance spectra from a non-biological
subject (e.g., a piece of printer paper) without using the excitation light. The integration time
was set at 30 ms, 100 ms, and 500 nm and the total number of the spectra acquired were 400.
This experiment procedure was repeated twice: one without using the built-in boxcar smoothing
function and the other with. The acquired spectra were preprocessed to reduce their spectral

49

resolution to 5 nm. The time history of the diffuse reflectance signal at a given wavelength
(Rd(λa,t)) was retrieved from the data set. To analyze the temporal variation Rd(λa,t) during the
recording period, the standard deviation of Rd(λa,t) was calculated. Furthermore, the distribution
characteristics of Rd(λa,t) were reviewed using histogram analysis.

Finally the frequency

spectral composition of Rd(λa,t) was analyzed using Fourier transformation.
2. Quantify the noise level and the stability from the light source. The main purpose of this substudy was to determine the noise originating from the excitation light source as well as its output
stability. The spectroscopy system was used to acquire diffuse reflectance spectra from a nonbiological sample (e.g., a piece of printer paper) with the excitation light turned on. The
integration time of the spectroscopy system was set at 30 ms and the total number of spectra
acquired was 400. The spectral acquisition was carried out after a fixed amount of the heating
time of the white light source. The heating time used in this study was 0 second, 30 seconds, 40
seconds, 1 minute, 2 minutes, 3 minutes, 4 minutes, and 5 minutes. The boxcar smoothing
function was used in this study. The acquired spectra were preprocessed to reduce their spectral
resolution to 5 nm. The time history of the diffuse reflectance signal at a given wavelength
(Rd(λa,t)) was retrieved from the data set. To analyze the effects of the heating time on the
temporal variation Rd(λa,t), the standard deviation of Rd(λa,t) was calculated and plotted as a
function of the heating time. Furthermore, the distribution characteristics of Rd(λa,t) was
reviewed as a function of heating time using the histogram analysis. Finally the frequency
spectral composition of Rd(λa,t) was analyzed as a function of the heating time using Fourier
transformation.
Using the data from the light source stability evaluation, the S/N of the diffuse
reflectance spectra at various signal strength levels was also evaluated. Here the mean value of
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Rd(λa,t) was calculated (Rd mean (λa)) and subtracted from Rd(λa,t) to yield the noise component
of Rd(λa,t) (Rdnoise(λa,t)). Finally, the S/N(λa) was calculated by Rd mean (λa)/STD(Rdnoise(λa,t)),
where STD is the calculation of standard deviation. The S/N(λa) was evaluated between 400 and
850 nm, where the main diffuse reflectance spectral band was, and its relationship with the
magnitude of the signal was determined.
4.3.3. Results
4.3.3.1. Spectrometer Noise Analysis
A typical Rd(λa,t) recorded without excitation light is shown in Figure 4.7, and its corresponding
frequency spectrum is shown in Figure 4.8. Since the excitation light and the ambient light were
off, Rd(λa,t) recorded under such a condition represents the spectral signal (i.e., noise spectrum
NS(λa,t)) originating from the spectrometer itself. It is noted that there are two components in
the NS(λa,t) of the spectrometer: a DC component and an AC component. The DC component is
believed to be originated from the dark current of the detector of the spectrometer and is
wavelength and time independent. Therefore, it can be easily estimated by calculating the mean
of NS(λa,t). The AC component of NS(λa,t) is a random fluctuation; its frequency spectrum
suggests that it strongly resembles white noise (i.e., the power spectral density is relative uniform
over the entire frequency spectral range). The histograms of the AC component (Figure 4.9)
suggest that the magnitude of this random fluctuation has normal distribution characteristics.
The maximum and minimal magnitudes of the AC component are about + 9 and – 9,
respectively, and they are wavelength and integration time independent (Figure 4.10). The
standard deviation of the AC component is about 3, which is also wavelength and integration
time independent (Figure 4.11).

Since the maximal spectral intensity of the existing

spectrometer is 4096 au; the maximum signal to noise ratio of the diffuse reflectance spectra
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recorded would be S/N = 4096 au/18 au = 227. In order to maintain the signal to noise level
above 20, the true signal in Rd(λa,t) has to be greater than 360 au.
The application of the real-time boxcar smoothing significantly reduces the AC
components in NS(λa,t), as shown in Figures 4.12 and 4.13, as well as the magnitude of its
frequency components. According the mean and standard deviation calculation of smoothed
NS(λa,t) shown in Figures 4.8 and 4.9, the smooth function effectively provides a 10-fold
reduction of the spectrometer noise. More importantly, the boxcar smoothing can be performed
in real time and hence does not affect the goal of continuously acquiring diffuse reflectance
spectra at 33 Hz. It also allows detection of weak fluctuations in diffuse reflectance signals
resulting from the regional alterations in physiological characteristics of the investigated tissue.
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Figure 4.7: Rd(λa,t) at λa = 400, 600, and 800 nm. The integration time is 30 ms, and the total
number of spectra acquired (i.e., the number of data points along the time axis) is 400.
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Figure 4.8: Frequency spectra of Rd(λa,t) at λa = 400, 600, and 800 nm. The integration time is
30 ms.
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Figure 4.9: The histograms of the AC component of NS(λa,t) at λa = 400, 600, and 800 nm.
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Figure 4.10: The difference between Max and Min of NS(λa,t) (i.e., Max(NS)-Min(NS)) within a
single recording period between 400 and 850 nm. The legend indicates the integration time used.
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Figure 4.11: The standard deviation of NS(λa,t) within a single recording period as a function of
wavelength. The legend indicates the integration time used.
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Figure 4.12: Smoothed Rd(λa,t) at λa = 400, 600, and 800 nm. The integration time is 30 ms,
and the total number of spectra acquired is 400. Here boxcar smoothing with a window size of
20 was used to smooth the individual spectrum (i.e., Rd(λ)). The smoothing was performed in
real-time during the spectral acquisition.
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Figure 4.13: Frequency spectra of smoothed Rd(λa,t) at λa = 400, 600, and 800 nm. The
integration time is 30 ms, and the total number of spectra acquired is 400. Here boxcar
smoothing with a window size of 20 was used to smooth the individual spectrum (i.e., Rd(λ)).
The smoothing was performed in real-time during the spectral acquisition.
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Figure 4.14: The difference between Max and Min of the smoothed NS(λa,t) (i.e., Max(NS)Min(NS)) within a single recording period between 400 and 850 nm. The legend indicates the
integration time used.
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Figure 4.15: The standard deviation of the smoothed NS(λa,t) within a single recording period as
a function of wavelength. The legend indicates the integration time used.
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4.3.3.2. Light Source Characteristics
Since the new spectroscopy system aims to investigate temporal variations in the physiological
characteristics of the brain, it is instrumental that the light source does not introduce additional
noise to the recorded spectra. The light source used in the new spectroscopic system is a CW
tungsten light source; therefore, the main source of the noise would be the drifting of the output
power of the light source. As shown in Figures 4.16 and 4.17, the output power of the light
source is dependent of the heating time allowed. Immediately after the white light source is
turned on, it is noticed that Rd(λa,t) steadily decreases as a function of time and this decline trend
is wavelength independent. This indicates that the overall output power of the light source
decreases gradually during the initial operation. The existence of this declining trend
significantly increases the low frequency component of Rd(λa,t), which could overwhelm slowvarying physiological signals such as low frequency hemodynamic oscillation. Thirty seconds
after the light source was turned up, it is noticed that the drifting of Rd(λa,t) became much less
significant and the output power of the light source reached a steady state.

When the light

source is allowed to heat up for at least 30 seconds, the noise characteristics of Rd(λa,t), which is
the AC component of Rd(λa,t), is comparable to that of the spectrometer in terms of magnitude,
magnitude distribution, and frequency composition.
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Figure 4.16: Time history of Rd(λa,t) at λa = 400, 600, and 800 nm. Heating time is (a) 0 second,
(b) 30 seconds, (c) 1 minutes, and (d) 5 minutes. Note the mean value of Rd(λa,t) within one
recording period was subtracted from Rd(λa,t) in these plots.
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Figure 4.17: Frequency spectra of Rd(λa,t) at λa = 400, 600, and 800 nm. Heating time is (a) 0
second, (b) 30 seconds, (c) 1 minutes, and (d) 5 minutes.
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4.4. Discussion and Conclusions
The probe design analysis shows that the source detector separation in a fiberoptic probe designs
strongly influences the sensitivity of the measured diffuse reflectance signals to the variations at
different depth of the cortex. While increasing the source detector separation allows detection of
deep abnormality within the cortex, the trade-off is low S/N, which is especially severe in the
wavelength region where the scattering and absorption properties are high. Furthermore, this
trade-off would significantly impact the capability of performing high speed time dependent
diffuse reflectance spectral acquisition from the cortex.

It is found that the optical probe

designed for the static spectroscopy system provides an investigation depth of ~ 1 mm, which
encompasses the second and the third layers of the cortex. Since the dynamic measurement aims
to probe the hemodynamics of the cortex and the vascular density in layer two and three of the
cortex is large, it is possible to use the existing optical probe to investigate the hemodynamic
characteristics of the epileptic cortex as a function of time.
The noise analysis of the spectrometer and the light source reveals distinct noises
characteristics for each device. The spectrometer contributes two types of noises: a DC one
originating from the dark current of the detector and an AC one similar to the white noise. The
DC noise of the spectrometer is wavelength and integration time independent, and can be easily
removed by subtracting the mean from the recorded signal. The AC component is random and
has a broad frequency spectral band (i.e., white noise) and cannot be removed using the
conventional filtering techniques. Nevertheless, the results of the noise study show that
smoothing the diffuse reflectance spectra using a boxcar filter significant reduces the magnitude
of the AC component of the spectrometer noise. Therefore it is possible to utilize this filter in
real time to reduce the noise introduced by the spectrometer in the recorded data. The noise from
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the light source, on the other hand, is a low frequency one: the output power of the light source
decreases gradually during the first 30 seconds of the operation and then reaches a steady state.
In order to avoid the interference of output instability of the light source to the time dependent
diffuse reflectance signal records, it is recommended that the light source should be turned on at
least 30 seconds prior to a single spectral acquisition process. In conclusion, the analysis
performed in this chapter provides valuable insights into the construction of a time dependent
diffuse reflectance spectroscopy system for in vivo epileptic cortex study. More importantly, it
suggests that the static spectroscopy system (the diffuse reflectance part) could be used to
investigate the hemodynamic characteristics of the human cortex with some modifications to the
data acquisition software and hardware designs of the controller and the system.

These

modifications were carried out and the dynamic system was used in another in vivo human study.
Details about this study can be found in the next chapter.
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5. Improving the quality of time-dependent, diffuse reflectance spectroscopic signals
measured from in vivo brain during craniotomy by reducing motion artifacts
5.1. Introduction
Spectroscopy-based optical diagnostic technologies have been investigated and evaluated widely
over the past two decades; they are primarily used to detect pre-cancer in various tissue organs
[93, 130-134] and guide tumor resection intraoperatively [51, 69, 135, 136]. These technologies
are built upon the principle of light-tissue interactions: light absorption and scattering inside a
biological tissue are governed by the tissue’s structural and compositional characteristics and
these intrinsic characteristics are altered by disease and/or injury [133, 137-141]. These
technologies hold several advantages over existing diagnostic technologies, in that they are
relatively inexpensive, highly portable, and can be used real-time. To make these technologies
applicable within an in vivo or intraoperative environment, a sterilized contact probe often is
employed to achieve remote sensing from in vivo tissue. The probe typically is held by the hand
of an operator. One common problem with such a practice is motion artifacts in the acquired
data. Unintentional hand movements or tremors alter the pressure of the probe against the target
tissue or shift the site of investigation. Ultimately, these movements are incorporated into the
data as noise or artifacts. A couple of earlier reports have suggested that probe pressure does not
significantly affect fluorescence intensity of the cervix [143, 144]. A similar finding was noted in
a study in which Raman spectroscopy was used to detect pre-cancerous lesions within the
gastrointestinal tract [145]. However, several other studies have shown that excessive probe
contact pressure, resulting from hand movements, can lead to strong alterations in the
hemodynamic and metabolic characteristics of local tissue [146-151]. In addition, the effect of
varying probe contact pressure on acquired optical spectral data is tissue type dependent: the
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softer the tissue, the greater the effect [142]. Despite this recognition, the intrinsic characteristics
of the spectral artifacts induced by hand motions have not yet been thoroughly investigated, and
no systematic approach to combat this obstacle has been proposed.
In this paper, we report the results of an in vivo study of the brains of pediatric patients
undergoing epilepsy surgery, so as to quantify the spectral and temporal artifacts induced by
hand motions. Specifically, time-dependent diffuse reflectance spectra were acquired from the
normal cortex of patients during epilepsy surgery using a fiber-optic spectroscopy system. Two
distinct methods of spectral data acquisition were compared: one with the fiber-optic probe held
by the surgeon’s hand during data acquisition, and the other with the probe held by a mechanical
probe holder. The probe holder was devised to eliminate hand-motion artifacts in the recording
and to counteract any spontaneous movements of the in vivo brain. Recordings from the two
data-acquisition methods were compared in the time, frequency, and wavelength domains, using
both descriptive and inferential statistics. From these results, the characteristics of spectral
artifacts induced by hand movements were determined and characterized.
5.2. Materials and Methods
5.2.1. Instrumentation
The instrumentation for in vivo diffuse reflectance spectral acquisition consisted of a fiberoptical probe and a portable spectroscopic system. It was calibrated using a calibrated tungsten
halogen light source (LS-1-CAL, Ocean Optics, Dunedin, FL) in order to remove any spectral
alterations induced by the instrument.

Details of this system can be found in a previous

publication by our group [69].
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5.2.2. Design of the Probe Holder
A mechanical probe holder was designed and engineered to eliminate the need for a surgeon to
hold the optical probe throughout a single data acquisition procedure. The introduction of this
holder enabled us to identify and, hence, quantify the spectral alterations induced by hand
movements. The three critical design criteria of the probe holder were: (1) it had to be able to
withstand the ethylene oxide gas sterilization procedure; (2) it had to maintain a stable
investigation location of the probe; and (3) it should maintain constant probe-contact pressure, if
feasible, against the in vivo brain tissue. The final design of the probe holder is depicted in
Figure 5.1. To meet the sterilization criterion, medical grade Stainless Steel 361 was used to
construct the entire holder. To meet the stability criterion, the probe holder was designed to be
used in conjunction with the Greenberg self-retaining retractor system. This approach reduced
the susceptibility of the probe holder to movements of the patient during data acquisition, as the
Greenberg system [152] was attached directly to the Mayfield head clamp (Integra LifeSciences
Corp. Cincinnati OH, USA) which was attached to the surgical bed. The center of the probe
holder is a stainless-steel tube with an inner diameter slightly larger than the diameter of the
optical probe. The optical probe is inserted through the tube and secured using a side screw. To
enable movement of the optical probe along its primary axis, the center tube was attached to the
frame of the holder via a two-bar track system (Figure 5.1).

To further facilitate axial

movements of the optical probe, four springs were used in the track system to suspend the probe.
The combined spring constant of this suspension system is 250 N/m. Since the free weight of the
probe is about 26 g, the displacement of the springs was about 1 mm when the probe was loaded
to the probe holder. Using the flat punch indentation model of viscoelastic solids derived by
Harding and Sneddon [153] as well as the shear modulus of the brain reported by Green et al
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[154], it was found that the addition of the damping springs in the probe holder would also
reduce the variation in probe contact pressure, resulting from the spontaneous brain movements,
by about 20% (Table 5.1). This type of variation in probe contact pressure may be further
minimized by reducing the overall spring constant. The trade-off of such an approach, however,
would be a significant increase in the loading displacement of the springs, and hence the size of
the probe holder.
Brain Movement
(mm)
0.1
0.5
1
Reduction (%)

Contact Force (N)
k=0
0.00635
0.03175
0.0635

k = 245 N/m
0.00508
0.0254
0.0508
20%

k = 50 N/m
0.001905
0.009525
0.01905
80%

Table 5.1: The effects of the damping springs on the probe contact force. The calculations
were conducted using the shear modulus of the brain = 5K Pa. Here k is the total spring
constant of the probe holder, and k = 0 represents the probe holder without damping
mechanism.
5.2.3. Data Acquisition and Preprocessing
In this study, in vivo time-dependent diffuse reflectance spectra Rd(λ,t) were acquired from the in
vivo brains in the operating room from pediatric patients who were undergoing epilepsy surgery.
A total of 18 patients were enrolled in the study. From each patient, data was collected from one
normal site. There was a patient from whom the data was collected from other normal sites as
well. Hence, the total number of sites was 20. The study was approved by the IRBs at Miami
Children’s Hospital and Florida International University. Informed written consent was obtained
from the parents or guardians of each participant. The patients were divided evenly into two
groups. In one group, data acquisition was performed with the probe holder (Holder Group). In
the other group, the probe holder was not used (Hand Group).
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(a)
(b)
Figure 5.1: (a) Schematic of the mechanical holder for the fiber optic probe. Here h = w = 1
inch and a = b = 1 inch. (b) The probe holder is attached to a Greenberg retractor system
during in vivo data acquisition.

In this trial, spectral data were acquired only from normal cortex, as defined by
intraoperative electrocorticography and pre-operative imaging. Prior to data acquisition, each
investigated site was rinsed with saline to remove surface blood, and the surgeon gently placed
the optical probe in direct contact with the target tissue. In addition, the broadband white light
source was pre-heated for at least 30 seconds to stabilize its output. Sequentially, 400 Rd(λ,t)
were acquired from the investigated site at a rate of 30 spectra per second (i.e., 30 ms integration
time). Upon completion of spectral acquisition, the white light was turned off and a baseline
spectrum was acquired to document the influence of ambient light. Every stage of the study
protocol was carried out under the careful supervision of the surgeons, such that patient care was
not compromised.
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A standard data pre-processing routine was applied to all acquired Rd(λ,t), so as to
eliminate spectral variations induced by the instrumentation and ambient light [69]. During the
spectral pre-processing procedure, the range of Rd(λ,t) was reduced to 400-850 nm with a
wavelength interval of 5 nm. These pre-processing procedures yielded a set of calibrated diffuse
reflectance spectra Rdcal(λi,t).
5.2.4. Data Analysis
Rdcal(λi,t) was analyzed in time, frequency and temporal correlation domains to identify the
characteristics of spectral alterations induced by hand movements. Furthermore, the degree of
improvement in the quality of Rdcal(λi,t) attributable to the probe holder was assessed
quantitatively.
To characterize the temporal alterations induced by hand movements, Rdcal(λi,t) from the
Holder and the Hand groups were compared empirically by an experienced spectral analyzer
(WCL). Time variations in Rdcal(λi,t) at a given wavelength were quantified further using its
percentage standard deviation, which is calculated as

%STD_Rdcal(λi) = STD(Rdcal(λi,t))/MEAN(Rdcal(λi,t)),

(5.1)

where STD is the standard deviation calculation along the time axis, MEAN is the overall
average calculation along the time axis, and λi = 400 nm to 850 nm at 50 nm intervals. Finally,
statistical comparisons were performed of %STD_Rdcal(λi) from the Holder and Hand groups to
estimate the degree of improvement which can be attributed to the probe holder on the quality of
acquired data.
To investigate wavelength-dependency of the temporal spectral alterations in Rdcal(λi,t) induced
by hand movements, temporal correlation analysis of Rdcal(λi,t) was conducted. Here, two
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signals within a single recording set, Rdcal(λi,t) and Rdcal(λref,t), were used to calculate correlation
coefficients r(λi,λref,t) for a fixed time window (∆t), expressed as

r (λi , λref , t ) =

COV [ Rd (λi , t : t + Δt ), Rd (λref , t : t + Δt )]i
STD[ Rd (λi , t : t + Δt )]* STD[ Rd (λref , t : t + Δt )]

(5.2)

where COV is the calculated covariance. In this analysis, λref= 800 nm was used as it is in the
spectral region where hemoglobin absorption is not prominent, and the window size used was 25
samples (i.e., ∆t = 750 ms). Again, r(λi,λref,t) from the Holder and Hand groups were empirically
evaluated to identify wavelength-dependency of spectral alterations in Rdcal(λi,t) induced by hand
movements. Furthermore, the mean of r(λi,λref,t) over the entire recording duration, denoted as
MEAN(r(λi, λref, t)), was calculated. Here, the range of λi was 400 to 850 nm at 50 nm intervals.
Finally, statistical comparisons were performed of MEAN(r(λi, λref, t)) from the Holder and Hand
groups to estimate the extent of improvement which can be attributed to the probe holder on the
quality of acquired data.
The frequency composition of Rdcal(λi,t) was analyzed to determine the frequency characteristics
of the spectral alterations induced by hand motions. To eliminate the contribution of the DC
component to the analysis, the mean intensity over the entire recording period was removed from
Rdcal(λi,t). That is

Rdcal_ac(λi) = Rdcal(λi, t) – MEAN(Rdcal(λi,t)

(5.3)

Fourier transformation then was applied to Rdcal_ac(λi), which produced a frequency spectrum
FT_ λi(f). The absolute value of FT_ λi(f) was computed to yield FTabs_λi(f),which shows the
magnitudes of the frequency components.

From FTabs_λi(f), locations of the prominent
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frequency components were identified and their correlations with the physiological
characteristics of the brain were explored. The power spectral energy of FTabs_λi(f), P(λi),was
calculated by integrating [FTabs_λi(f)]2 over the entire frequency range, for λi = 400 to 850 nm in
50 nm intervals. Finally, statistical comparisons were performed with P(λi) from the Holder and
Hand groups to estimate improvement in the quality of the acquired data caused by the probe
holder.
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5.3. Results
5.3.1 Temporal Variations in Rdcal(λi, t)

(a)

(b)

(c)

(d)

Figure 5.2: (a) and (b) are the representative Rdcal(λ,t) from the Holder and Hand groups,
respectively. (c) and (d) are %STD_Rdcal(λi) calculated using Rdcal(λ,t) from the Holder and
Hand groups, respectively. Figure legends p1 to p10 are sites from Probe Holder group and h1
to h10 are sites from Hand Held group.
Temporal variations in Rdcal(λ,t) from the Holder group were insignificant (Figure 5.2a) at all
wavelengths as shown in Table 5.2. In contrast, strong variations often were observed in Rdcal(λ,t)

from the Hand group. These variations did not possess any predictable nature (e.g., cycling) and
often occurred at all wavelengths. Results from the quantitative analysis of Rdcal(λ,t) in the time
domain suggest that time variations in Rdcal(λ,t) from the Holder group, in general, were much
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less than those from the Hand group (Figures 5.3c and d). Two sample t-tests (for normal data)
and the Kolmogorov-Smirnov test (for non-normal data) of %STD_Rdcal(λi) further confirmed
that the decrease in temporal variations in Rdcal(λ,t), resulting from the employment of the probe
holder, was statistically significant (Table 5.2). In the Hand group, it also is noted that
%STD_Rdcal(λi) between 400 and 600 nm was stronger than that beyond 600 nm, which suggests
that Rdcal(λ,t) between 400 and 600 nm was more susceptible to hand movements.
5.3.2 Temporal Correlation in Rd(λ,t)

(a)

(b)

(c)

(d)

Figure 5.3: (a) and (b) are the representative correlation coefficient maps, r(λi,λref,t), from the
Holder and Hand groups, respectively. (c) and (d) are MEAN(r(λi, λref, t)) calculated using
Rdcal(λ,t) from the Holder and Hand groups, respectively. Figure legends p1 to p10 are sites
from Probe Holder group and h1 to h10 are sites from Hand Held group.
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The correlation coefficient maps, r(λi,λref,t), from the Holder group were featureless, as
shown in Figure 5.3a; r(λi,λref,t) fluctuated randomly between -0.5 and 0.5 along the time axis as
well as the wavelength axis. In contrast, r(λi,λref,t) from the Hand group often possessed vertical
bands, where high temporal correlations (| r |> 0.8) were found among the majority of
wavelength bands. The temporal durations of these vertical bands varied. Moreover, this vertical
band may be divided into two segments along the wavelength axis; r(λi,λref,t) above 600 nm was
greater than 0.8 and r(λi,λref,t) below 600 nm was less than -0.8. Because of these vertical bands,
MEAN(r(λi, λref, t)) from the Hand group was generally higher than that from the Holder group.
This difference, according to a two sample t-test and Kolmogorov-Smirnov test (wherever
applicable), was statistically significant (Table 5.2). Also, it is noted that the difference in
MEAN(r(λi, λref, t)) between the two data groups was more pronounced between 400 and 600 nm
than over the remaining wavelengths.
5.3.3 Frequency Composition
Low temporal variations in Rdcal(λ,t) from the Holder group were clearly reflected in their
corresponding frequency spectra (Figure 5.4a); they were very similar to the frequency spectrum
of spectrometer noise (no light). However, FTabs_λi(f) from the Holder group often processed a
prominent frequency component between 1 and 2 Hz, which was related to the heart rate of the
studied subject. As expected, strong temporal variations in Rdcal(λ,t) from the Hand group led to
more frequency components in their corresponding FTabs_λi(f).

These random frequency

components, however, were not related to physiological characteristics of the brain (i.e., heart
rate and breathing rate). Statistically, P(λi) from the Holder group was significantly smaller than
P(λi) between 400 and 850 nm (Table 5.2).
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(a)

(b)

(c)
(d)
Figure 5.4: (a) and (b) are the representative FTabs_λi(f) from the Holder and Hand groups,
respectively The green dots on peaks represent the respiration and heartbeat respectively. (c)
and (d) are P(λi) calculated using FTabs_λi(f) from the Holder and Hand groups, respectively.
Figure legends p1 to p10 are sites from Probe Holder group and h1 to h10 are sites from Hand
Held group.
Domain
%STD_Rdcal(λ
i)
MEAN(r(λi,
λref, t))
P(λi)

400
nm
0.003
*
0.000
0.000

450
nm
0.001

500
nm
0.001

550
nm
0.001

600
nm
0.001

650
nm
0.001

0.001
*
0.000

0.000

0.001
*
0.000

0.000

0.000

700
nm
0.000
*
0.000

0.000

0.000

0.000

0.000

750
nm
0.001

800
nm
0.000

0.003
*
0.000

0.000

850
nm
0.001
*
0.003
*
0.000

Table 5.2: Results of statistical comparisons (p values) * indicates that a non-parametric test
(Kolmogorov-Smirnov) was used.
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5.4. Discussion and Conclusions
In this study, the effects of hand motions on in vivo optical investigation were evaluated
qualitatively and quantitatively in time and frequency domains. Hand motion induced
significantly random variations in acquired diffuse reflectance spectra, and its effects in the short
wavelength region (i.e., below 600 nm) are more prominent. These random variations in the
time domain translate to a significant increase in the power spectral energy in the frequency
domain. These variations can be strong enough to overwhelm the meaningful signals generated
by the in vivo physiological characteristics of the investigated tissue (e.g., cardiac cycle). Even
more interesting is that the temporal correlation of these spectral alterations exhibit peculiar
wavelength dependencies: their phases at different wavelength bands may be completely
opposite under certain circumstances. The introduction of the probe holder mentioned in this
paper significantly reduces these temporal variations in the acquired diffuse reflectance spectra,
while preserving the native signals from in vivo brain.
Through the frequency domain and temporal correlation analyses of Rdcal(λ,t), it was
found that oscillations in the diffuse reflectance spectra, acquired using the probe holder,
coincide with the rates of the beating heart (1 to 2 Hz) and breathing (0.2 to 0.5 Hz). This
indicates that heart beats and breaths alter local hemodynamic characteristics, namely blood
volume and hemoglobin oxygenation. These changes, in turn, modify the absorption properties
of the cortex and, hence, the measured diffused reflectance signals. Spectral alterations induced
by probe movement can be classified into two categories, based upon the nature of the
movement.

For lateral probe movements, the spectral alterations originate from spatial

variations in the optical properties of the cerebral cortex.

This commonly appears as

synchronized oscillations in diffuse reflectance signals at all wavelengths, and explains the high-
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correlation-coefficient vertical bands in the correlation coefficient maps r(λi,λref,t). For axial
probe movement, the spectral alterations are induced primarily by the changes in the regional
hemodynamics [142].

The changes in hemoglobin oxygenation would lead to wavelength

dependent increase/decrease in Rdcal(λ,t), and hence the band characteristics in its corresponding
correlation coefficient maps r(λi,λref,t).

The deformation of the cortex induced by axial probe

movement, however, should not change its scattering properties because the biological tissue has
been treated as an incompressible material in studies of tissue mechanical properties.
The potential to utilize signal processing techniques to remove motion artifacts from
recorded signals like Rd(λ,t) have been explored by various groups, including ours. Because of
the nonlinear and unpredictable nature of the motion artifacts, conventional frequency domain
filtering would not provide satisfactory results. Consequently, nonlinear filters - such as adaptive
filtering, wavelet filtering, and independent component analysis - must be used. Based on our
experience thus far, none of the existing filtering techniques effectively removes the motion
artifacts in Rd(λ,t). This is because of the nonlinear effects of motion artifacts on diffuse
reflectance signals at various wavelengths. Therefore, we believe that it is better to reduce the
effects of motion artifacts during the recording stage (using a mechanical holder).
Attempts to stabilize the optical probe during in vivo spectral acquisition procedures have
been made by several groups, where a plain mechanical structure, like a pincer, was used [142,
155, 156]. Such an approach would eliminate the lateral and axial movements of the optical
probe induced by the hand, but might not address the irregular probe contact issue induced by the
spontaneous movements of the in vivo tissue. Based on our experience, in vivo brain movements
in a surgical environment are significant, because of cardiac cycle and ventilation under
anesthesia. A plane mechanical holder would yield inconsistent probe contact pressure. Due to
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the softness of the brain, inconsistent probe contact pressures lead to detrimental tissue
deformation and, thereby, regional alterations in hemodynamics [142]. The probe holder design
proposed and tested in this paper took this concern into consideration; the springs in the probe
holder reduce contact pressure significantly when the probe is placed lightly in contact with the
brain surface. In addition, it reduces the amount of force (and, hence, the degree of brain
deformation) required to move the probe along its primary axis. In other words, the probe will
move according to brain surface movement, without drastically changing probe contact pressure.
This improvement consequently reduces motion artifacts in the optical data.
Optical Spectroscopy is being applied increasingly for differentiating various healthy
body tissues from unhealthy ones. Technological and theoretical advances make it easier to apply
it to the study of brain tissue. However, if attention is not paid to sources of signal variations,
researchers risk drawing the wrong conclusions from their data. This is especially true for timedependent recordings. In this study the characteristics of the motion artifacts induced by an
operator’s hand when holding an optical probe, as well as the spontaneous movements of brain
tissue were quantitatively demonstrated. Moreover, a new probe holder design that can contain
motion artifacts to a great extent was introduced; hence, small time-dependent variations in
diffuse reflectance spectra associated with the intrinsic characteristics of the brain can be
captured.
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6. Interictal Characteristics of Epileptic Cortex Measured by Dynamic Diffuse Reflectance
Spectroscopy
6.1. Introduction
Epilepsy surgery is performed for the purpose of freeing children from intractable epilepsy and
hence adverse effects of recurrent seizures. Detection of epileptic cortex can be achieved via
studying/observing its abnormal pathophysiological characteristics. One major feature widely
used in current practice is the electrophysiological characteristics of the epileptic cortex:
abnormal electrical discharges during the ictal and interictal periods can be captured and
localized using EEG and ECoG [157, 158]. The structural abnormality induced by epilepsy may
be detected by MRI/CT noninvasively and by optical spectroscopy intraoperatively (see Chapter
3). Several imaging studies have also shown that epileptic cortex and its surrounding tissue are
hypometabolic between seizures [159], and become hypermetabolic when seizure occurs [160].
The alterations in the metabolic state of the epileptic cortex may directly or indirectly affect the
regional hemodynamics [75, 161]; non-invasive imaging studies [160] and intraoperative
intrinsic optical signal (IOS) measurements [73] from human subjects show a transient increase
in regional blood flow, cerebral blood volume, and hemoglobin oxygenation when seizure
occurs. Nevertheless, the hemodynamic characteristics of epileptic cortex during the interictal
period have not yet been investigated. Here, the dynamic diffuse reflectance spectroscopy
developed in the previous chapter was used to measure the interictal hemodynamic
characteristics of pediatric epileptic cortex in vivo. The results of the study reveals that the
epileptic cortex possesses unique temporal hemodynamic characteristics, which may be used
localize and demarcate epileptic cortex intraoperatively.
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6.2. Materials & Methods
The details of the instrumentation used in this study, time dependent diffuse reflectance
spectroscopy system, can be found in the previous chapter and hence not repeated here. It was
used to directly acquire diffuse reflectance spectra in the visible wavelength region (i.e., 400 to
850 nm) as a function of time. For each patient studied, the optical investigation was performed
prior to lesion removal and the investigated tissue sites were selected by the surgeons. At least
four distinct sites were investigated in a single patient study.
Prior to the spectral acquisition, each investigated site was rinsed with saline to remove
surface blood. The light source was turned on at least 30 seconds prior to the data acquisition to
allow its output to stabilize. With the probe placed gently in direct contact with the cortical
surface, diffuse reflection spectra Rd(λ,t) were recorded continuously for about 12 seconds at a
33 Hz rate. A biopsy was taken from each investigated site, except of those classified as
normal/functional cortical surface (i.e., outside the resection zone). All biopsies acquired were
processed using the conventional tissue processing/sectioning routine and then stained using
hematoxylin and eosin. The stained tissue sections were then read by a neuropathologist to
identify those histopathological abnormalities associated with epileptic cortex. Every stage of
the study protocol was carried out under the careful supervision of the surgeons such that the
patient care was not compromised.
It has been shown that the cortex outside the zone of resection, defined by intraoperative
ECoG, do not necessary represent the true normal cortex. Therefore, pediatric brain tumor
patients undergoing brain tumor surgery were recruited in this study for the purpose of
establishing the normal baseline. The measurement procedure used in the tumor patient study
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was identical to that described above. The sites of investigation were selected from the cortex
outside the zone of resection defined by the pre-surgical imaging studies.
Prior to the data analysis, all recorded Rd(λ,t)s were calibrated to remove the artifacts
induced by instrumentation, which yielded Rdcal(λ,t). The mechanical probe holder disclosed in
Chapter 5 was not used in this study because it was not readily available at the beginning of this
study. Therefore, Rdcal(λ,t) shown here inevitably contained a certain level of motional artifacts
originated from the movement of surgeon’s hand. According to results of several in vitro studies
regarding hand-motion artifacts (not published), it was found that motion artifacts often exhibit
statistically high covariance among all optical wavelengths in Rdcal(λ,t). This unique
characteristic led to the development of a new signal process routine for removal of this type of
motion artifacts using principal component analysis (PCA) [162]. PCA (or truncated singular
value decomposition) filtering is based on the subtraction of the eigenvector components
exhibiting high covariance (i.e., motion artifacts) in the data. The principal components of the
data covariance were calculated using a standard procedure for singular value decomposition
(SVD). Specifically, Rdcal(λ,t) is a m×n rectangular matrix and can be rewritten in the following
form:
Rdcal(λ,t) = u1 s1v1T + u2 s2v2T +… + unsnvnT

(6.1)

where s1 ≥ s2 ≥ … ≥ sn ≥ 0, U is an m×n orthogonal matrix, S is a n×n diagonal matrix, V is
another n×n orthogonal matrix. Since motion artifacts will typically have a highly covariant
structure, they are generally captured in the first few (strongest) eigenvector components.
Therefore, they may be removed by subtracting first na of unsnvnT from Rdcal(λ,t). That is
,

,

∑

(6.2)
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To analyze the time-varying characteristics of Rdtrue(λ,t), correlation coefficient (CC)
analysis was used. CC analysis was performed between a reference signal, Rdtrue(λref,t), and a
comparison signal, Rdtrue(λcomp,t). This calculation yielded γ(λref,λcomp,t) representing the
temporal correlation between the two diffuse reflectance signals. Here the reference signal Rdtrue
(λref,t) was chosen at λref = 800 nm because it is not influenced by hemodynamics (i.e.,
absorption) as much as those in the visible wavelength region and is more sensitive to the
structural characteristics (i.e., scattering) of the investigated tissue. The window size for CC
calculation was 25, which was short enough to capture the transient temporal variations in
Rdtrue(λcomp, t) and, at the same time, long enough to reduce the effects of the random
spectrometer noises to the analysis. The comparisons of γ(λref, λcomp, t) between epileptic cortex
(defined by ECoG) and normal cortex were carried out using empirical methods.
To uncover the underlying mechanisms of the unique features in γ(λref, λcomp, t), a Monte
Carlo simulation for photon migration (see Chapter 4) was used to stimulate Rd(λ,t) with varying
blood volume factor (BVF) and oxygen saturation ( SatO2 ). The alterations in BVF and SatO2
directly affected the absorption coefficient µa(λ) [1/cm] of the biological medium. That is

μa (λ ) = BVF [ SatO2 × μaHbO (λ ) + (1 − SatO2 ) × μaHb (λ )]
2

(6.3)

where μ aHbO2 (λ ) is the absorption coefficient of oxygenated blood [1/cm] and μ aHb (λ ) is the
absorption coefficient of deoxygenated blood [1/cm]. The simulated Rd(λ,t)s were analyzed
using the correlation analysis method described above to produce γsim(λref, λcomp, t), which were
then compared with those from the in vivo studies to determine the contribution of temporal
variations in hemodynamics to the variations in γ(λref, λcomp, t).
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6.3. Results and Discussion
In this study 19 tumor patients and 26 epilepsy patients were enrolled. The demographic
information of these patients can be found in Table 6.1. A total of 41 sets of Rd(λ,t)s were
acquired from the tumor patients, which forms the tumor normal group. A total of 137 sets
Rd(λ,t)s were obtained from the epilepsy patients: 88 sets were from the cortex within the zone
of resection (epileptic abnormal group) and 49 sets from the cortex outside the zone of resection
(epileptic normal group).
Figure 6.1 shows a representative result from the CC analysis of Rd(λ,t) from the tumor
normal group. Obviously the hand movement of the surgeon introduced significant temporal
variations in Rd(λ,t) at all wavelengths. γ(λref = 800 nm, λcomp,t) calculated using the data
without PCA filtering shows that high temporal correlation was found at all wavelengths during
the entire recording duration. This suggests that the spectral artifacts induced by hand motion, in
this case, are not highly wavelength dependent. When PCA filtering is applied to the Rd(λ,t),
significant changes in γ(λref = 800 nm, λcomp,t) are observed. When the first and second PCs are
removed from Rd(λ,t), γ(λref = 800 nm, λcomp,t) shows an interesting two-horizontal band
characteristics: γ(λref = 800 nm, λcomp,t) above λcomp = 600 nm shows a strong positive correlation
(i.e., γ > 0.8) and γ(λref = 800 nm, λcomp,t) below λcomp = 600 nm shows a strong negative
correlation (i.e., γ > - 0.8). Removing more PCs from the raw data does not change the two-band
characteristic in γ(λref = 800 nm, λcomp,t) until the total number of PCs removed exceeds 50,
where γ(λref = 800 nm, λcomp,t) becomes completely random and its values vary approximately
between -0.3 to +0.3. The above mentioned trend in γ(λref = 800 nm, λcomp,t), resulting from PCA
filtering, is found to be very common among the data sets from the tumor normal group (Table
6.2). However, the number of PCs that have to be removed in order to reveal the two band
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characteristics in γ(λref = 800 nm, λcomp,t) is site dependent. This may be explained by the level
of motion artifacts as well as their spectral and temporal characteristics in the original data.
CC analysis reveals many unique wavelength-dependent temporal variations in Rd(λ,t)
from the epileptic cortex group (ECoG defined). One of the representative results from the CC
analysis of Rd(λ,t) from the epileptic cortex group (ECoG defined) is shown in Figure 6.2.
Again prior to PCA filter, Rd(λ,t) contains a certain level of motion artifacts and its γ(λref = 800
nm, λcomp,t) shows several high-correlation (> 0.8) vertical bands during the recording period.
When first three or four PC’s are removed from Rd(λ,t), γ(λref = 800 nm, λcomp,t), it shows an
interesting four-horizontal band characteristics: a strong positive correlation (i.e., γ > 0.8) is
found between 600 nm and 800 nm and a strong negative correlation (i.e., γ > - 0.8) between 400
nm and 450 nm.

Filtered Rd(λ,t)s between 450 nm and 500 nm show positive temporal

correlation with the reference signal, while Rd(λ,t)s between 500 nm and 600 nm show negative
temporal correlation with the reference signal. Removing more than 15 PCs from the raw data
makes γ(λref = 800 nm, λcomp,t) completely random and its values vary approximately between 0.3 to +0.3. Within the data set from epileptic cortex, neither a predictable alteration trend in
γ(λref = 800 nm, λcomp,t) nor a two-band characteristic observed in the tumor normal group,
resulting from PCA filtering, could be observed consistently (Figure 6.3 and Table 6.3). This
suggests the two-band characteristic in γ(λref = 800 nm, λcomp,t) may be unique to the normal
cortex.
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Date

Age & Sex

Number
Sites

of Date

Age &
Sex
Epilepsy Abnormal
050107 17M
050207 3M
060407 14M
060607 8M
061807a 15F
062607 15F
121207
012907 15F
021207 8M
022707 2M
022807 2M
031907 12M
091907 7M
100307 3F
100407 15F
101107 15F
102307 2M
102407 10F
110507 7F
073107 13F
081407 18M
081507 10M
082707 12F

Tumor Normal
090507
9F
2
091707
10M
2
092107
5F
2
040108
6F
2
040308
9F
2
051408
8F
3
061308
5F
2
082808
6F
2
112108
3F
2
120508
14F
3
121208
10F
2
022509
2F
2
022607
13F
2
051507
9F
2
060507
6M
2
061207
12F
2
061807
10M
1
062707
11F
4
080707
1M
2
110607
4M
5
062607
15F
3
062907
9M
2
072407
6M
2
072507
18F
2
Table 6.1: Demographic information of the epilepsy and tumor
presented.
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Number
Sites

of

5
3
2
2
2
3
4
3
1
5
3
2
3
8
2
3
3
3
3
4
2
5
4
patients recruited in the study

Case

Site

PC
Variance Single Double Multiple No Band
Removed Reduced Band Band
Band

090507

1
2
3
4
4
5
1
2
1
2

10
4
1
1
4~10
X
4~10
3~4
1
X

98.83%
96.11%
95.29%
88%
96~98%
X
96~78%
90~93%
93.59%
X

1
2
3
1
2
1
2
1

1,2,3,4
X
1~10
12
2
10
1~10
X

88.89%
X
99.90%
98.90%
99.37%
99.39%
99.49%
X

3
1
2
3
1
4
1
3
1
2
1
2
1
2
1
2
2
1

10
4
15
15
10
2
25
2~10
2
4~10
10
10~15
15
15
15
15
X
1,2,3

97.76%
98.35%
99.79%
99.79%
99.32%
94.88%
99.85%
99.89%
93%
91~97%
96.50%
90~94%
95%
96%
93%
98%

091707
092107
040108
040308
*No strong
motion
artifacts

051408

061308
082808
112108

Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y

* PCA
Filtering is
not very
helpful

120508

121208
022509
022607
051507
060507
061207
061807
062707

Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y

98%

Y
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2
2,3
53~66%
Y
3
3,4
89~90%
Y
4
4~10
98-99%
Y
080707 1
10
99.29%
Y
2
0
0%
Y
Table 6.2: PCA filtering and band characteristics for the data sets from the tumor normal group.
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Date

Site

PC
Removed

Single
Band

Double
Band

Multiple No
Band
Band

Pathology

050107

4

10~15

Y*

N/A

5
7
8
9
2
3
5
4

25
1~2
10
10
X
1,2
25
X

Y
Y
Y
Y

Y

N/A
N/A
Normal
Normal
Normal
Normal
Normal
Abnormal

5
5

Y
Y

Abnormal
Abnormal

Y

Abnormal
N/A
N/A

1
2

X
1~4
10
1
2~10
2~10
15
0~3
4~15
1~3
4~15
0~4
10
2
2~3
4
10~15
2~3
10~15

4
1
1
2
3
4
5

10~15
0
1
1
25
4
1~2

* Band cutoff
is 500 nm

050207

060407

Y
Y
Y

* PCA
Filtering is not
helpful

060607

061807a

062607

6
1
2
2
3

121207

1
2
5
7

012907
* With 2
additional
weak bands

021207
022707
* Noisy

Y
Y
Y
Y
Y

Abnormal
Y
Y
Y
Y

Normal
Normal

Y
Y
Y
Y

Normal
Abnormal
Abnormal

Y
Y
Y

Normal
Normal

Y
Y
Y
Y
Y
Y
Y
89

Abnormal
Normal
Abnormal
Normal
Normal
Abnormal
Normal

022807
* 3rd and 4th
bands are
weak

031907
091907

100307
*Cutoff at 700
nm

1
2
3

3
2
3
10~15

3
4
1
2
6
1
2
3

X
3~10
2
1
1
1
4~10
1~2

4

100407
101107

102307

102407

5
9
10
12
1
2
1
2
3
1
2
3
2
3

110507

110607

5
1
3
4
1
2
3
4

Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y*

10~25
0~15
25
10
10
10~15
10~15
1~15
X
15
X
10
15
10
15
2
4~25
3
4~25
10
10
1
0~4
X
15~25
10~15
1~15

Normal
Abnormal
Normal
Normal
Abnormal
Normal
Normal
Abnormal
N/A
Abnormal
N/A

Y
Y

N/A

Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y

N/A
Abnormal
Abnormal
Abnormal
N/A
N/A
Abnormal
Abnormal
Abnormal
Normal
Abnormal
Abnormal

Y
Y

Normal
Y

Y

Normal
Y
Y

Y
Y
Y
Y
Y
Y
Y
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Abnormal
Normal
Normal
N/A
Abnormal
Abnormal
N/A
N/A

062607

5
2

1~15
25

3
6

10~15
1

1

0~4
10~15
0~10
15
1~2
X
1~2
1
3~15
1~2
3~15
1~4
10~25
15
4
X
10~15
10~15
15~25
2
2~4
0
0

Y

N/A
Normal

Y*

*Weak 2-band
* Cutoff at
650 nm

062907

2
072407
072507

073107

3
4
1
2
1
2

081407
081507

082707

4
5
3
4
2
3
4
6
7
1

Y

Abnormal
Abnormal

Y*
Y

Abnormal

Y
Y

Normal
Y
Y
Y
Y
Y

Normal
Normal
Normal
Normal

Y
Y

Normal
Y

Y

Abnormal
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y*

N/A
Abnormal
Normal
Normal
Abnormal
Normal
Normal
Normal
Normal
N/A

* Cutoff at
700 nm

2

2
Y
N/A
15
Y
3
1
Y
N/A
5
1
Y
Abnormal
Table 6.3: Pathology, PCA filtering and band characteristics for the data sets from the epilepsy
abnormal group.
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Figure 6.1: CC analysis of Rd(λ,t) from Site 1 of from Patient 022607 (normal cortex).
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Figure 6.2: CC analysis of Rd(λ,t) from Site 1 of Patient 121207 (epileptic cortex).
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Figure 6.3: CC analysis of Rd(λ,t) from Site 1 of Patient 091907 (epileptic cortex). The motion
artifact is minimal in this set of data; PCA filtering does not change γ(λref = 800 nm, λcomp,t).
Using the simulated Rd(λ,t) generated by the Monte Carlo simulation for photon
migration, insights about the underlying physiological mechanisms of the band characteristics in
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γ(λref = 800 nm, λcomp,t). When blood volume oscillates and SatO2 remains constant, as shown in
Figure 6.4, the entire γ(λref = 800 nm, λcomp,t) displays high temporal correlation (γ = 1). When
blood volume remains constant and SatO2 oscillates, horizontal band characteristics appear in the
corresponding γ(λref = 800 nm, λcomp,t). However, these multi-band features were not observed in
any of the in vivo data recorded. Since the increase in blood volume would also lead to an
increase in the scattering property (i.e., increase in the number of red blood cells), a separate
simulation was carried out using oscillating BVF and the scattering coefficient and the two-band
characteristic, as shown in Figure 6.1, was recreated in the corresponding γ(λref = 800 nm,
λcomp,t). This attests to the physiological origin of the band characteristics in γ(λref = 800 nm,
λcomp,t) from the in vivo cortex.
The results of this study also show the effectiveness of PCA filtering in removing spectral
artifacts in Rd(λ,t) induced by hand motion. When the motion spectral artifacts are synchronized
temporarily at all wavelengths and much stronger than the actual biological signals, they usually
occupy the first few principal components and hence can be easily removed using PCA filtering.
Since the magnitude of the motion artifacts does vary from case to case, it is rather difficult to
predetermine how many PCs should be removed in order to minimize the effects of motion
artifacts. It is suggested here that sufficient PCs should be removed in order to eliminate most of
the vertical bands while preserving the horizontal bands. When too many PCs are removed from
the original signals, γ(λref = 800 nm, λcomp,t) will represent the correlation of the noise and hence
be completely random.
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Figure 6.4: γ(λref = 800 nm, λcomp,t) (bottom) calculated from simulated Rd(λ,t) (top). Here BVF
is oscillated between 5% and 3% periodically; and SatO2 is fixed at 3%.

Figure 6.5: γ(λref = 800 nm, λcomp,t) (bottom) calculated from simulated Rd(λ,t) (top). Here BVF
is fixed at 3%; and SatO2 is oscillated between 100% and 60% periodically.
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6.4. Conclusions
Time dependent physiological properties of pediatric epileptic cortex were characterized during
the interictal period using dynamic diffuse reflectance spectroscopy. The recorded spectral data
were calibrated and conditioned using the PCA filtering method; their temporal characteristics
were analyzed using the correlation analysis. The results of the analysis reveal some unique
wavelength dependent temporal characteristics of epileptic cortex (i.e., multiple horizontal bands
in the correlation coefficient map γ(λref = 800 nm, λcomp,t)). According to the simulation model,
these characteristics are caused by the temporal alterations in the hemodynamics of cortex. The
positive outcome of the study also supports the concept of using time dependent diffuse
reflectance spectroscopy to detect epileptic cortex intraoperatively.
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7. Summary and Future Work
The primary objective of this dissertation is to prove that fluorescence and diffuse reflectance
spectroscopy can detect interictal pathophysiological characteristics associated with pediatric
epileptic cortex in an intraoperative environment.

To achieve this goal, three aims were

designed and studies were carried out, and they were:
(1) To identify static fluorescence and diffuse reflectance spectral features those differentiate
between normal and epileptic pediatric cortex defined by pathology.
(2) To develop a portable fiberoptic spectroscopic system with capability to capture dynamic
diffuse reflectance spectra from in vivo brain in an intraoperative environment.
(3) To identify dynamic diffuse reflectance spectral features associated with pediatric epileptic
cortex defined by ECoG and pathology.
The results of the first study show that static diffuse reflectance spectroscopy and its
combination with static fluorescence spectroscopy can be used to effectively differentiate
between epileptic cortex (defined by histology) and normal cortex in vivo with a high degree of
accuracy. The success of this study is attributed to the fact that static hemodynamic
characteristics of epileptic cortex, namely hemoglobin concentration and oxygenation, are very
different from those of the normal cortex. These findings imply the feasibility of using diffuse
reflectance spectroscopy to localize the histopathological abnormalities associated with pediatric
epileptic cortex in an intraoperative environment. The same study also shows that fluorescence
spectroscopy alone is insufficient in differentiating between epileptic cortex and normal cortex,
which is attributed to the modulation of cortical optical properties to the fluorescence signals.
To maximize the efficiency of optical spectroscopy in detecting and localizing epileptic
cortex intraoperatively, the static system was upgraded to investigate histopathological
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abnormalities deep within the epileptic cortex, as well as to detect unique temporal
pathophysiological characteristics of epileptic cortex. Detection of deep abnormalities within the
epileptic cortex required a redesign of the fiberoptic probe. A simulation model for photon
migration was developed to evaluate the correlation among source-detector separation (i.e.,
design factor), depth of investigation, and signal strength. Based on the insights produced by the
simulation model, it was concluded that the optimal source-detection separation is between 0.6 to
1 mm and the illumination wavelength should be beyond 600 nm for deep penetration. To
capture time dependent characteristics of epileptic cortex, a dynamic diffuse reflectance
spectroscopy system was designed and constructed. The system is capable of continuously
recording diffuse reflectance spectra from the in vivo brain at a high rate (33 Hz) for at least 12
seconds. The performance of the system was confirmed through the analysis of the signal to
noise ratio of the spectrometer and the stability of the excitation light source. A mechanical
probe holder was also designed and constructed to maintain the probe contact pressure and
contact point during the time dependent measurements. The improvement of the data quality
introduced by the probe holder was confirmed using an in vivo human study.
In the third study, the dynamic diffuse reflectance spectroscopy system was used to
characterize in vivo pediatric epileptic cortex. The results of this study shows that some unique
wavelength dependent temporal characteristics (e.g., multiple horizontal bands in the correlation
coefficient map γ(λref = 800 nm, λcomp,t)) can be found in the time dependent recordings from
epileptic cortex defined by ECoG. According to the simulation model, these characteristics are
caused by the temporal alterations in the hemodynamics of cortex. The positive outcome of the
study also supports the concept of using time dependent diffuse reflectance spectroscopy to
detect epileptic cortex intraoperatively.
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While the research results disclosed in this dissertation support the central hypothesis of
the research project, there are still many improvements that have to be implemented before
optical spectroscopy can make a positive impact on future epilepsy surgery. First of all, the
analysis of the time dependent recording needs to be enhanced to fully realize the potential of
dynamic diffuse reflectance spectroscopy in intraoperative localization and demarcation of
epileptic cortex. Secondly, the dynamic fluorescence spectroscopy should be developed and
tested because it will assess the dynamic metabolic characteristics of epileptic cortex, which is
not achievable using the existing technologies. Thirdly, the in vivo data acquisition should be
carried using a non-contact means (i.e., remote sensing) to completely eliminate the artifacts
induced by inconsistent probe contact pressure as well as brain movement. Finally, the optical
recording should be performed simultaneously with the electrical recording (i.e., ECoG) to
uncover the correlation between the electrical activities of epileptic cortex with their
physiological characteristics.

103

LIST OF REFERENCES
1.

Williams J, Sharp G.B., Epilepsy. In: K.O. Yeates, M.D. Ris and H.G. Taylor, Eds,
“Pediatric neuropsychology: Research, theory, and practice”, The Guilford Press, New
York 2000:47-73

2.

Thompson PJ, Trimble MR: “Neuropsychological aspects of epilepsy in
neuropsychological assessment of neuropsychiatric disorders”, in Neuropsychological
Assessment of Neuropsychiatric Disorders, 2nd ed. Edited by Grant IG, Adams KM.
New York, Oxford University Press, 1996:263-287

3.

A.S. Winkler, M. Schaffert, and R. Schmutzhard, “Epilepsy in resource poor countries –
suggestion of an adjusted classification,” Epilepsia 48:1029-1030 (2007)

4.

F. Frohlich, M. Bazhenov, V. Iragui-Madoz, and T.J. Sejnowski, “Potassium Dynamics
in the Epileptic Cortex - New Insights on an Old Topic,” The Neuroscientist 14, 422-433
(2008)

5.

M. Bazhenov, I. Timofeev, F. Frohlich, and T.J. Sejnowski, “Cellular and network
mechanisms of electrographic seizures,” Drug Discovery Today: Disease Models Spring
5, 45-57 (2008)

6.

D. Pare´ and E.J. Lang, “Calcium electrogenesis in neocortical pyramidal neurons in
vivo,” Eur. J. Neurosci.10, 3164–3170 (1998)

7.

N.C. de Lanerolle, T.S. Lee and D.D. Spencer, “Astrocytes and epilepsy,”
therapeutics 7, 424-38 (2010)

8.

Y. Fujiwara-Tsukamoto, Y. Isomura, A. Nambu, and M. Takada, “Excitatory gaba input
directly drives seizure-like rhythmic synchronization in mature hippocampal CA1
pyramidal cells,” Neuroscience 119, 265–275 (2003)

9.

William H. Theodore, “Does Serotonin Play a Role in Epilepsy?” Epilepsy Curr 3, 173–
177 (2003)

10.

A. Friedman, C.J. Behrens, U. Heinemann, “Cholinergic dysfunction in temporal lobe
epilepsy,” Epilepsia 48,126-30 (2007)

11.

Yukitoshi Takahashi, “Infections as causative factors of epilepsy, Future Neurology,” 1,
291-302 (2006)

12.

S.R. Chandana, S. Movva, M. Arora, T. Singh, “Primary brain tumors in adults,” Am
Fam Physician 77, 1423-1430 (2008)

104

Neuro-

13.

E.G. Neal, H. Chaffe, R.H. Schwartz, M.S. Lawson, N. Edwards, G. Fitzsimmons, A.
Whitney, J.H. Cross, “The ketogenic diet for the treatment of childhood epilepsy: a
randomised controlled trial,” Lancet Neurol 7, 500–506 (2008)

14.

J.M. Freeman, E.H. Kossoff, and A.L. Hartman, “The ketogenic diet: one decade later,”
Pediatrics, 119, 535–43 (2007)

15.

S. Thammongkol, D.F. Vears, J. Bicknell-Royle, J. Nation, K. Draffin, K.G. Stewart, I.E.
Scheffer, and M.T. Mackay, “Efficacy of the ketogenic diet: which epilepsies respond?,”
Epilepsia 5, e55-9 (2012)

16.

W.H. Tresche, “Pediatric Epilepsy: Diagnosis and therapy,” Edited by W. Edwin Dodson
and John M. Pellock, New York, Demos, illustrated, Ann Neurol. 34, 419-446 (1993)

17.

Heck, Christi, Sandra L Helmers, and Christopher M DeGiorgio, “Vagus nerve
stimulation therapy, epilepsy, and device parameters: scientific basis and
recommendations for use,” Neurology 59, S31-S37(2002)

18.

P. Jayakar, “Invasive EEG monitoring in children: when, where, and what?” J Clin
Neurophysiol 16, 408-18 (1999)

19.

J.M. Paolicchi, P. Jayakar, P. Dean, I. Yaylali, G. Morrison, A. Prats, T. Resnik, L.
Alvarez, and M. Duchowny, “Predictors of outcome in pediatric epilepsy surgery,”
Neurology 54, 642-7 (2000)

20.

P. Jayakar, M. Duchowny, and T.J. Resnick, “Subdural monitoring in the evaluation of
children for epilepsy surgery” J Child Neurol 9, 61-6 (1994)

21.

P. Jayakar, M. Duchowny, T.J. Resnick, and L.A. Alvarez, “Localization of seizure foci:
Pitfalls and caveats,” J Clin Neurophysiol 8, 414-31(1991)

22.

H. Jones, and M. Smith, “Awake craniotomy,” Contin Educ Anaesth Crit Care Pain 14,
189-92 (2004)

23.

P.G. Matz, C. Cobbs, and M.S. Berger, “Intraoperative cortical mapping as a guide to the
surgical resection of gliomas,” J Neurooncol. 42, 233-245 (1999)

24.

P.D. Adelson, “The surgical management of epilepsy in childhood: A review,”
Neurosurg Q 6, 1–20 (1996)

25.

R. Wennberg, F. Quesney, A. Olivier, and T. Rasmussen, “Electrocorticography and
outcome in frontal lobe epilepsy,” Electroencephalogr Clin Neurophysiol 106, 357-68
(1998)

26.

P. Jayakar, L.A. Alvarez, M. Duchowny, and T.J. Resnick, “Intraictal activation in the
neocortex: A marker of the epileptogenic region,” Epilepsia 35, 489-94 (1994)

105

27.

P. Jayakar, L.A. Alvarez, M. Duchowny, and T.J. Resnick, “A safe and effective
paradigm to functionally map the cortex in childhood,” J Clin Neurophysiol 9, 288-93
(1992)

28.

P. Jayakar, “Invasive EEG monitoring in children: when, where, and what?,” J Clin
Neurophysiol 16, 408-18 (1999)

29.

Raj D. Sheth, “Intractable pediatric epilepsy: Presurgical evaluation,” Seminars in
pediatric neurology 7, 158-165 (2000)

30.

F.E. Jansen, A.C. van Huffelen, A. Algra, and O. van Nieuwenhuizen, “Epilepsy surgery
in tuberous sclerosis: a systematic review,” Epilepsia 48, 1477-1484 (2007)

31.

Hema Patel, Bhuwan P. Garg, Omkar N. Markand, “Bathing epilepsy: Video/EEG
recording and literature review,” Journal of Epilepsy 7, 290-294 (1994)

32.

V. Villanueva, A. Gutiérrez, M. García, A. Beltrán, J. Palau, R. Conde, P. Smeyers, P.
Rubio, E. Gómez, T. Rubio, A. Sanjuán, C. Avila, J.C. Martínez, V. Belloch, R. PérezVelasco, A. Campo, J. Domínguez, “Usefulness of Video-EEG monitoring in patients
with drug-resistant epilepsy,” Neurologia 26, 6-12 (2011)

33.

A.T. Berg, F.M. Testa, S.R. Levy, and S. Shinnar, “Neuroimaging in children with newly
diagnosed epilepsy: a community-based study,” Pediatrics September 106, 527-32(2000)

34.

U.C. Wieshmann, “Clinical application of neuroimaging in epilepsy,” J Neurol
Neurosurg Psychiatry 74, 466-70 (2003)

35.

Andrea Bernasconi, Neda Bernasconi, Boris C. Bernhardt and Dewi
Schrader, “Advances in MRI for ‘cryptogenic’ epilepsies,” Nature Reviews Neurology
7, 99-108 (2011)

36.

T.M. Salmenpera, and J.S. Duncan, “Imaging in epilepsy,” J Neurol Neurosurg
Psychiatry 76, iii2-iii10 (2005)

37.

B. Alkonyi, H.T. Chugani, and C. Juhász, “Transient focal cortical increase of interictal
glucose metabolism in Sturge-Weber syndrome: implications for epileptogenesis,”
Epilepsia. 52, 1265-72 (2011)

38.

K. Benedek, C. Juhasz, D.C. Chugani, O. Muzik,and H.T. Chugani, “Longitudinal
changes in cortical glucose hypometabolism in children with intractable epilepsy,” J
Child Neurol 21, 26-31 (2006)

39.

Ross P. Carne, Terence J. O'Brien, Christine J. Kilpatrick, Lachlan R. MacGregor, Lucas
Litewka, Rodney J. Hicks, and Mark J. Cook, “MRI-negative PET-positive temporal lobe

106

epilepsy (TLE) and mesial TLE differ with quantitative MRI and PET: a case control
study,” BMC Neurol. 7, 16 (2007)
40.

D.C. Alsop, A. Connelly, J.S. Duncan, A. Hufnagel, C. Pierpaoli, and F.J. Rugg-Gunn,
“Diffusion and perfusion MRI in epilepsy,” Epilepsia 43, 69–77 (2002)

41.

Baumgartner Christoph, Serles Wolfgang, Leutmezer Fritz, Pataraia Ekaterina, Gudrun
Gröppel, Johanna Bacher, Susanne Aull, Wolfgang Serles, Martha Hoffmann, Fritz
Leutmezer, Thomas Czech, Daniela Prayer, Uwe Pietrzyk, Susanne Asenbaum, Ivo
Podreka, “Preictal SPECT in temporal lobe epilepsy: Regional cerebral blood flow is
increased prior to electroencephalography-seizure onset,” The Journal of Nuclear
Medicine 39, 978-982 (1998)

42.

Mateo Calderon-Arnulphi, Ali Alaraj, Sepideh Amin-Hanjani, William W Mantulin,
Chiara M Polzonetti, Enrico Gratton, and Fady T Charbel, “Detection of cerebral
ischemia in neurovascular surgery using quantitative frequency-domain near-infrared
spectroscopy,” Journal of Neurosurgery 106, 283-90(2007)

43.

D. Le Bihan, J.F. Mangin, C. Poupon, C. Clark, S. Pappata, N. Molko, and H. Chabriat,
“Diffusion tensor imaging: concepts and applications,” J Magn Reson Imag 13, 534–546
(2001)

44.

A. Assaf Bassam, B. Mohamed Feroze, J. Abou-Khaled Karine, Williams J. Michael, S.
Yazeji May, Haselgrove John, and H. Faro Scott, “Diffusion tensor imaging of the
hippocampal formation in temporal lobe epilepsy,” American journal of
neuroradiology 24, 1857-62 (2003)

45.

D. Zumsteg, and H.G. Wieser, “Presurgical evaluation: current role of invasive EEG,”
Epilepsia 41, S55-S60 (2000)

46.

A. Kuruvilla, and R. Flink, “Intraoperative electrocorticography in epilepsy surgery:
useful or not?,” Seizure 12, 577-584 (2003)

47.

S.A. Prahl, “Optical Absorption of Hemoglobin,” (1999), http://omlc.ogi.edu/
spectra/hemoglobin/index.html

48.

R. M. Doornbos, R. Lang, M. C. Aalders, F. W. Cross, and H. J. Sterenborg, “The
determination of in vivo human tissue optical properties and absolute chromophore
concentrations using spatially resolved steady-state diffuse reflectance spectroscopy,”
Phys Med Biol, 44, 967-81 (1999)

49.

A. M. Nilsson, C. Sturesson, D. L. Liu, and S. Andersson-Engels, “Changes in spectral
shape of tissue optical properties in conjunction with laser-induced thermotherapy,” Appl
Opt 37, 1256-67 (1998)

107

50.

J. Swartling, S. Palsson, P. Platonov, S. B. Olsson, and S. Andersson-Engels, “Changes
in tissue optical properties due to radio-frequency ablation of myocardium,” Med. Biol.
Eng. Comput. 41, 403 (2003)

51.

W.C. Lin, S. A. Toms, M. Johnson, E. D. Jansen, and A. Mahadevan-Jansen, "In vivo
brain tumor demarcation using optical spectroscopy," Photochemistry and Photobiology
73, 396-402 (2001)

52.

F. Bevilacqua, D. Piguet, P. Marquet, J. D. Gross, B. J. Tromberg, and C. Depeursinge,
“In vivo local determination of tissue optical properties: applications to human brain,”
Applied Optics 38, 4939-4950 (1999)

53.

G. Zonios, J. Bykowski, and N. Kollias, “Skin melanin, hemoglobin, and light scattering
properties can be quantitatively assessed in vivo using diffuse reflectance spectroscopy,”
J. Invest Dermatol 117, 1452-1457 (2001)

54.

M. G. Muller, T. A. Valdez, I. Georgakoudi, V. Backman, C. Fuentes, S. Kabani, N.
Laver, Z. M. Wang, C. W. Boone, R. R. Dasari, S. M. Shapshay, and M. S. Feld,
“Spectroscopic detection and evaluation of morphologic and biochemical changes in
early human oral carcinoma,” Cancer 97, 1681-1692 (2003)

55.

D. Hidovic-Rowe and E. Claridge, “Modeling and validation of spectral reflectance for
the colon,” Physics in Medicine and Biology 50, 1071-1093 (2005)

56.

G. Zonios, L. T. Perelman, V. Backman, R. Manoharan, M. Fitzmaurice, J. V. Dam, and
M. S. Feld, "Diffuse reflectance spectroscopy of human adenomatous colon polyps in
vivo," Applied Optics 38, 6628-6637 (1999)

57.

S. Srinivasan, B. W. Pogue, S. Jiang, H. Dehghani, C. Kogel, S. Soho, J. J. Gibson, T. D.
Tosteson, S. P. Poplack, and K. D. Paulsen, “Interpreting hemoglobin and water
concentration, oxygen saturation, and scattering measured in vivo by near-infrared breast
tomography,” PNAS 100, 12349-12354 (2003)

58.

N. Shah, A. Cerussi, C. Eker, J. Espinoza, J. Butler, J. Fishkin, R. Hornung, and B.
Tromberg, “Noninvasive functional optical spectroscopy of human breast tissue,” PNAS
98, 4420-4425 (2001)

59.

I. Georgakoudi, B. C. Jacobson, J. V. Dam, V. Backman, M. B. Wallace, M. G. Muller,
Q. Zhang, K. Badizadegan, D. Sun, G. A. Thomas, L. T. Perelman, and M. S. Feld,
“Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in
patients with Barrett's esophagus,” Gastroenterology 120, 1620-1629 (2001)

60.

W. T. Knoefel, N. Kollias, D. W. Rattner, N. S. Nichioka, and A. L. Warshaw,
“Reflectance spectroscopy of pancreatic microcirculation,” Journal of Applied
Physiology 80, 116-123 (1996)

108

61.

R. J. Nordstrom, L. Burke, J. M. Niloff, and J. F. Myrtle, "Identification of cervical
intraepithelial neoplasia (CIN) using UV-excited fluorescence and diffuse-reflectance
tissue spectroscopy," Lasers in Surgery and Medicine 29, 118-127 (2001)

62.

G. Zonios, L. Perelman, V. Backman, R. Manoharan, M. Fitzmaurice, J. Van Dam, and
M. Feld, "Diffuse Reflectance Spectroscopy of Human Adenomatous Colon Polyps In
Vivo," Appl. Opt. 38, 6628-6637 (1999)

63.

S. Bradley Robert, and Maureen S. Thorniley, “A review of attenuation correction
techniques for tissue fluorescence,” Journal of the Royal Society Interface the Royal
Society 3, 1-13 (2006)

64.

Avraham Mayevsky, and Gennady G. Rogatsky, “Mitochondrial function in vivo
evaluated by NADH fluorescence: from animal models to human studies,” American
journal of physiology-Cell physiology 292, C615-40 (2007)

65.

J. Wu, Y. Wang, L. Perelman, I. Itzkan, R.R. Dasari and M.S. Feld, “Time-resolved
multichannel imaging of fluorescent objects embedded in turbid media,” Opt. Lett. 20
489–91 (1995)

66.

Salomatina Elena, Muzikansky Alona, Neel Victor, and N. Yaroslavsky Anna,
“Multimodal optical imaging and spectroscopy for the intraoperative mapping of
nonmelanoma skin cancer,” Journal of Applied Physics 105, 102010-102010-7 (2009)

67.

D.J. Evers, B.H.W. Hendriks, G.W. Lucassen and T.J.M. Ruers, “Optical spectroscopy:
current advances and future applications in cancer diagnostics and therapy,” 8, 307-320
(2012)

68.

W.C. Lin, S.A. Toms, M. Motamedi, E.D. Jansen, A. Mahadevan-Jansen, “Brain tumor
demarcation using optical spectroscopy: an in vitro study,” Journal Of Biomedical Optics
5, 214-20 (2000)

69.

W.C. Lin, D.I. Sandberg, S. Bhatia, M. Johnson, S. Oh,and J. Ragheb, “Diffuse
reflectance spectroscopy for in vivo pediatric brain tumor detection”, Journal of
Biomedical Optics 15, 061709 (2010)

70.

S. Bhatia, J.R. Ragheb, M. Johnson, Sanghoon Oh, D.I. Sandberg, and W.C. Lin, “The
role of optical spectroscopy in epilepsy surgery in children,” Neurosurgery Focus. 25,
E24 (2008)

71.

S. Oh, T. Stewart, I. Miller, S. Bhatia, J. Ragheb, M. Duchowny, P. Jayakar P and W.C.
Lin, “In vivo optical properties of cortical tubers in children with tuberous sclerosis
complex (TSC): a preliminary investigation,” Epilepsia. 52, 1699-1704 (2011)

72.

M.M. Haglund, and D.W. Hochman, “Optical imaging of epileptiform activity in human
neocortex,” Epilepsia. 45, 43-7 (2004)

109

73.

T.H. Schwartz, “Optical imaging of epileptiform events in visual cortex in response to
patterned photic stimulation,” Cereb Cortex 13, 1287-98 (2003)

74.

Avraham Mayevsky, and Britton Chance, “Oxidation-reduction states of NADH in vivo:
from animals to clinical use,” Mitochondrion 7, 330-9 (2007)

75.

T.H. Schwartz, “Neurovascular Coupling and Epilepsy: Hemodynamic Markers for
Localizing and Predicting Seizure Onset,” Epilepsy Currents 7, 91–94 (2007)

76.

Markus G. Müller, Irene Georgakoudi, Qingguo Zhang, Jun Wu, and Michael S. Feld,
“Intrinsic fluorescence spectroscopy in turbid media: disentangling effects of scattering
and absorption,” Applied Optics 40, 4633-4646 (2001)

77.

V. Diekmann, W. Becker, R. Jurgens, B. Grozinger, B. Kleiser, H.P. Richter, and K.H.
Wollinsky, “Localisation of epileptic foci with electric, magnetic and combined
electromagnetic models,” Electroenceph clin Neurophysioly 106, 297–313 (1998)

78.

P. Kwan and M. J. Brodie, "Early identification of refractory epilepsy," N. Engl. J. Med.
342(5), 314-319 (2000).

79.

A. T. Berg, S. Shinnar, S. R. Levy, F. M. Testa, S. Smith-Rapaport, and B. Beckerman,
"Early development of intractable epilepsy in children: a prospective study," Neurology
56(11), 1445-52 (2001).

80.

J.H. Cross, P. Jayakar, D. Nordli, O. Delalande, M. Duchowny, H. G. Wieser, R.
Guerrini, and G. W. Mathern, "Proposed criteria for referral and evaluation of children
for epilepsy surgery: recommendations of the Subcommission for Pediatric Epilepsy
Surgery," Epilepsia 47(6), 952-9 (2006).

81.

J. Engel Jr.,"Surgery for seizures," N. Engl. J. Med.334(10), 647-652 (1996).

82.

A. S. Harvey, J. H. Cross, S. Shinnar, G. W. Mathern, and the Pediatric Epilepsy Surgery
Survey Taskforce, "Defining the spectrum of international practice in pediatric epilepsy
surgery patients," Epilepsia 49(1), 146-155 (2008).

83.

K. Chapman, E. Wyllie, I. Najm, P. Ruggieri, W. Bingaman, J. Lüders, P. Kotagal, D.
Lachhwani, D. Dinner, and H.O. Lüders, "Seizure outcome after epilepsy surgery in
patients with normal preoperative MRI," J. Neurol. Neurosurg Psychiatry 76(5), 710-3
(2005).

84.

M. Hemb, T. R. Velasco, M. S. Parnes, J. Y. Wu, J. T. Lerner, J. H. Matsumoto, S.
Yudovin, W. D. Shields, R. Sankar, N. Salamon, H. V. Vinters, and G. W. Mathern,
"Improved outcomes in pediatric epilepsy surgery: the UCLA experience, 1986-2008,"
Neurology 74(22),1768-75 (2010).

110

85.

F. Sperli, L. Spinelli, M. Seeck, M. Kurian, C. M. Michel, and G. Lantz, "EEG source
imaging in pediatric epilepsy surgery: a new perspective in presurgical workup,"
Epilepsia 47(6) 981-990 (2006).

86.

D. W. Roberts, A. Hartov, F. E. Kennedy, M. I. Miga, and K. D. Paulsen, "Intraoperative
brain shift and deformation: a quantitative analysis of cortical displacement in 28 cases,"
Neurosurgery 43(4), 749-758 (1998)

87.

C. Nimsky, O. Ganslandt, P. Hastreiter, and F. Fahlbusch, "Intraoperative compensation
for brain shift," Surg. Neurol. 56(6), 357-364 (2001).

88.

C. Nimsky, O. Ganslandt, S. Cerny, P. Hastreiter, G. Greiner, and R. Fahlbusch,
"Quantification of, visualization of, and compensation for brain shift using intraoperative
magnetic resonance imaging," Neurosurgery 47(5), 1070-1079 (2000).

89.

S. Ding, M. I. Miga, R. C. Thompson, P. Dumpuri, A. Cao, and B. M. Dawant,
"Estimation of intra-operative brain shift using a tracked laser range scanner," Conf. Proc.
IEEE Eng. Med. Biol. Soc. 848-851 (2007).

90.

E. Asano, C. Juhász, A. Shah, S. Sood and H. T. Chugani, "Role of subdural
electrocorticography in prediction of long-term seizure outcome in epilepsy surgery,"
Brain 132(Pt 4), 1038-1047 (2009).

91.

V. Jay and L. E. Becker, "Surgical pathology of epilepsy: a review," Pediatr.
Pathol.14(4), 731-750 (1994).

92.

R. Richards-Kortum and E. Sevick-Muraca, "Quantitative optical spectroscopy for tissue
diagnosis," Annu. Rev. Phys. Chem.47, 555-606 (1996).

93.

K. Sokolov, M. Follen, and R. Richards-Kortum, "Optical spectroscopy for detection of
neoplasia," Curr. Opin. Chem. Biol.6(5), 651-658 (2002).

94.

Z. Huang, A. McWilliams, H. Lui, D. I. McLean, S. Lam, and H. Zeng, "Near-infrared
Raman spectroscopy for optical diagnosis of lung cancer," Int. J. Cancer, 107(6), 10471052 (2003).

95.

A. Gillenwater, R. Jacob, R. Ganeshappa, B. Kemp, A. K. El-Naggar, J. L. Palmer, G.
Clayman, M. F. Mitchell, and R. Richards-Kortum, "Noninvasive diagnosis of oral
neoplasia based on fluorescence spectroscopy and native tissue autofluorescence," Arch.
Otolaryngol. Head. Neck. Surg. 124(11), 1251-1258 (1998).

96.

J. R. Mourant, I. J. Bigio, J. Boyer, R. L. Conn, T. Johnson, and T. Shimada,
"Spectroscopic diagnosis of bladder cancer with elastic light scattering," Lasers Surg.
Med. 17(4), 350-357 (1995).

111

97.

G. M. Palmer, C. F. Zhu, T. M. Breslin, F. S. Xu, K. W. Gilchrist, and N.
Ramanujam, "Comparison of multiexcitation fluorescence and diffuse reflectance
spectroscopy for the diagnosis of breast cancer," IEEE Trans. Biomed. Eng. 50(11),
1233-1242 (2003).

98.

I. J. Bigio and J. R. Mourant, "Ultraviolet and visible spectroscopies for tissue
diagnostics: fluorescence spectroscopy and elastic-scattering spectroscopy," Phys. Med.
Biol. 42(5), 803-814 (1997).

99.

G. A.Wagnieres, W. M. Star, and B. C. Wilson, "In vivo fluorescence spectroscopy and
imaging for oncological applications," Photochem. Photobiol. 68(5), 603-632 (1998).

100. D.A. Boas, T. Gaudette, G. Strangman, X. Cheng, J.J. Marota, and J.B. Mandeville,
"The accuracy of near infrared spectroscopy and imaging during focal changes in
cerebral hemodynamics," Neuroimage 13(1), 76-90 (2001).
101. A. Villringer, J. Planck, C. Hock, L. Schleinkofer, and U. Dirnagl, "Near infrared
spectroscopy (NIRS): a new tool to study hemodynamic changes during activation of
brain function in human adults," Neurosci. Lett. 154(1-2), 101-104 (1993).
102. M. Zhao, M. Suh, H. Ma, C. Perry, A. Geneslaw, and T. H. Schwartz, "Focal increases
in perfusion and decreases in hemoglobin oxygenation precede seizure onset in
spontaneous human epilepsy," Epilepsia 48(11), 2059-2067 (2007).
103. M. M. Haglund, "Optical imaging of visual cortex epileptic foci and propagation
pathways," Epilepsia 53(Suppl 1), 87-97 (2012).
104. J. Engel Jr, D. E. Kuhl, M. E. Phelps, and J. C. Mazziotta, "Interictal cerebral glucose
metabolism in partial epilepsy and its relation to EEG changes," Ann. Neurol. 12(6),
510-7 (1982).
105. G. Franck, B. Sadzot, E. Salmon, J. C. Depresseux, T. Grisar, J. M. Peters, M.
Guillaume, L. Quaglia, G. Delfiore, and D. Lamotte, "Regional cerebral blood flow and
metabolic rates in human focal epilepsy and status epilepticus," Adv. Neurol. 44, 935-48
(1986).
106. S. K. Kim, D. S. Lee, S. K. Lee, Y. K. Kim, K. W. Kang, C. K. Chung, J. K. Chung, and
M.C. Lee, "Diagnostic performance of [18F]FDG-PET and ictal [99mTc] HMPAO
SPECT in occipital lobe epilepsy," Epilepsia 42(12), 1531-40 (2001).
107. D. E. Kuhl, J. Engel Jr, M. E. Phelps, and C. Selin, "Epileptic patterns of local cerebral
metabolism and perfusion in humans determined by emission computed tomography of
18FDG and 13NH3," Ann. Neurol. 8(4) 348-360 (1980).
108. B.I. Lee, O.N. Markand, A.R. Siddiqui, H.M. Park, B. Mock, H.H. Wellman, R.M.
Worth, and M.K. Edwards, "Single photon emission computed tomography (SPECT)

112

brain imaging using N,N,N'-trimethyl-N'-(2 hydroxy-3-methyl-5-123I-iodobenzyl)-1,3propanediamine 2 HCl (HIPDM): intractable complex partial seizures," Neurology
36(11), 1471-1477 (1986).
109. B. Stefanovic, J. Warnking, E. Kobayashi and A. P. Bagshaw, "Hemodynamic and
metabolic responses to activation, deactivation and epileptic discharges," Neuroimage
28(1), 205-215 (2005).
110. J. S. Duncan, "Imaging and epilepsy," Brain 120(Pt 2), 339-377 (1997).
111. W. H. Theodore, R. Brooks, R. Margolin, N. Patronas, S. Sato S, R. J. Porter, L. Mansi,
D. Bairamian, and G. DiChiro, "Positron emission tomography in generalized seizures,"
Neurology 35(5), 684-690 (1985).
112. L. O. Kapucu, A. Serdaroglu, C. Okuyaz, G. Kose and K. Gucuyener, "Brain single
photon emission computed tomographic evaluation of patients with childhood absence
epilepsy," J. Child. Neurol. 18(8), 542-548 (2003).
113. M. C. Prevett, J. S. Duncan, T. Jones, D. R. Fish, and D. J. Brooks, "Demonstration of
thalamic activation during typical absence seizures using H2(15)O and PET," Neurology
45(7), 1396-1402 (1995).
114. G. R. Gordon, S. J. Mulligan, and B. A. MacVicar, "Astrocyte control of the
cerebrovasculature," Glia.55(12), 1214-1221(2007).
115. G. Balazsi, A. H. Cornell-Bell, and F. Moss, "Increased phase synchronization of
spontaneous calcium oscillations in epileptic human versus normal rat astrocyte cultures,"
Chaos.13(2), 515-518 (2003).
116. S. Ding, T. Fellin, Y. Zhu, S. –Y. Lee, Y. P. Auberson, D. F. Meaney, D. A. Coulter, G.
Carmignoto, and P. G. Haydon, "Enhanced astrocytic Ca2+ signals contribute to neuronal
excitotoxicity after status epilepticus," J. Neurosci. 27(40), 10674-10684(2007).
117. H. Hirase, L. Qian, P. Barthó, and G. Buzsáki, "Calcium dynamics of cortical astrocytic
networks in vivo," PLoS Biol. 2(4), E96 (2004).
118. A. Tashiro, J. Goldberg, and R. Yuste, "Calcium oscillations in neocortical astrocytes
under epileptiform conditions," J. Neurobiol. 50(1), 45-55 (2002).
119. A.G. Mignani and F. Baldini, "Biomedical sensors using optical fibers," Rep. Prog.
Phys., 59, 1-28 (1996)
120. Anil Kishen, Annie Shrestha, and Adeela Rafique, “Fiber optic backscatter spectroscopic
sensor to monitor enamel demineralization and remineralization in vitro,” World J Clin
Oncol. 2, 50-63 (2008)

113

121. L.H. Wang, S.L. Jacques, and L.Q Zheng, “MCML - Monte Carlo modeling of photon
transport in multi-layered tissues,” Computer Methods and Programs in Biomedicine 47,
131-146 (1995)
122. A. Wang, J. Bender, U. Utzinger, and R. Drezek, “Depth sensitive reflectance
measurements using obliquely oriented fiber probes,” J. Biomed. Opt. 10, 044017 (2005)
123. J. Pfefer, A. Agrawal, and R. Drezek, “Oblique-incidence illumination and collection for
depth-selective fluorescence spectroscopy,” J. Biomed. Opt. 10, 044016 (2005)
124. Florian E. W. Schmidt, “Development of a Time-Resolved Optical Tomography System
for Neonatal Brain Imaging,” PhD Thesis, University College London, (1999)
125. C. Von Economo, G.N. Koskinas, Basel: Karger, “Atlas of the cytoarchitectonics of the
adult human cerebral cortex (translated, revised and edited by L. C. Triarhou),” (2008)
126. S. Gebhart, W.C. Lin, A. Mahadevan-Jansen, “Normal and neoplastic brain tissue optical
properties using inverse adding-doubling,” Physics in Medicine and Biology 21; 51,
2011-27 (2006)
127. P. van der Zee, M. Essenpreis, and D. T. Delpy, "Optical properties of brain tissue,"
Photon Migration and Imaging in Random Media and Tissues, R. R. Alfano and B.
Chance, eds., Proc. SPIE 1888, 454-465 (1993)
128. A. N. Yaroslavsky, P. C. Schulze, I. V. Yaroslavsky, R. Schober, F. Ulrich and H.J.
Schwarzmaier, “Optical properties of selected native and coagulated human brain tissues
in vitro in the visible and near infrared spectral range,” Physics In Medicine and Biology
47, 2059-2073 (2002)
129. B. Fischl, and A.M. Dale, “Measuring the thickness of the human cerebral cortex from
magnetic resonance images,” Proc Natl Acad Sci USA 97, 11050-11055 (2000)
130. Bigio, I. and S. Bown, Spectroscopic sensing of cancer and cancer therapy: current status
of translational research. Cancer Biol Ther, 2004. 3(3): p. 259-267.
131. Brown, J.Q., et al., Advances in quantitative UV-visible spectroscopy for clinical and
pre-clinical application in cancer. Curr Opin Biotechnol, 2009. 20(1): p. 119-31.
132. Perelman, L.T., Optical diagnostic technology based on light scattering spectroscopy for
early cancer detection. Expert Rev Med Devices, 2006. 3(6): p. 787-803.
133. Bakker Schut, T.C., et al., In vivo detection of dysplastic tissue by Raman spectroscopy.
Anal Chem, 2000. 72(24): p. 6010-8.
134. Wang, T.D. and J. Van Dam, Optical biopsy: a new frontier in endoscopic detection and
diagnosis. Clin Gastroenterol Hepatol, 2004. 2(9): p. 744-53.

114

135. Haglund, M.M., M.S. Berger, and D.W. Hochman, Enhanced optical imaging of human
gliomas and tumor margins. Neurosurgery, 1996. 38(2): p. 308-17.
136. Sun, Y., et al., Fluorescence lifetime imaging microscopy for brain tumor image-guided
surgery. J Biomed Opt, 2010. 15(5): p. 056022.
137. Mayevsky, A. and G. Rogatsky, Mitochondrial Function In Vivo Evaluated by NADH
Fluorescence: From Animal Models to Human Studies. Am J Physiol Cell Physiol, 2006.
138. Benaron, D.A., et al., Continuous, noninvasive, and localized microvascular tissue
oximetry using visible light spectroscopy. Anesthesiology, 2004. 100(6): p. 1469-75.
139. Knotzer, H. and W.R. Hasibeder, Microcirculatory function monitoring at the bedside--a
view from the intensive care. Physiol Meas, 2007. 28(9): p. R65-86.
140. Mallia, R., et al., Oxygenated hemoglobin diffuse reflectance ratio for in vivo detection
of oral pre-cancer. J Biomed Opt, 2008. 13(4): p. 041306.
141. Wang, H.W., et al., Diffuse reflectance spectroscopy detects increased hemoglobin
concentration and decreased oxygenation during colon carcinogenesis from normal to
malignant tumors. Opt Express, 2009. 17(4): p. 2805-17.
142. Ti, Y. and W.C. Lin, Effects of probe contact pressure on in vivo optical spectroscopy.
Opt Express, 2008. 16(6): p. 4250-62.
143. Nath A, Rivoire K, Chang S, Cox D, Atkinson EN, Follen M, Richards-Kortum R. Effect
of Probe Pressure on Cervical Fluorescence Spectroscopy Measurements. J Biomed Opt
2004;9(3):523-33.
144. K Rivoire, A Nath, D Cox, EN Atkinson, R Richards-Kortum, M Follen. The Effects of
Repeated Spectroscopic Pressure Measurements on Fluorescence Intensity in the Cervix.
Am J Obstet Gynecol 2004;191(5):1606-17.
145. Shim MG, Song LM, Marcon NE, Wilson BC. In vivo near-infrared Raman spectroscopy:
demonstration of feasibility during clinical gastrointestinal endoscopy. Photochem
Photobiol 2000;72(1):146-50.
146. H Shangguan, SA Prahl, SL Jacques, LW Casperson. Pressure effects on soft tissues
monitored by changes in tissue optical properties. Proc. SPIE. Laser-Tissue Interaction
IX, 1998;3254:366-371.
147. Chan EK, Sorg B, Protsenko D, O’Neil M, Motamedi M, Welch AJ. Effects of
compression on soft tissue optical properties. IEEE J Quantum Electron. 1996;2(4):943950.

115

148. Wenliang Chen, Rong Liu, Kexin Xu, Ruikang K Wang. Influence of contact state on
NIR diffuse reflectance spectroscopy in vivo. J. Phys. D: Appl. Phys. 2005;38:2691-2695.
149. Reif R, Amorosino MS, Calabro KW, A'Amar O, Singh SK, and Bigio IJ. Analysis of
changes in reflectance measurements on biological tissues subjected to different probe
pressures. J Biomed Opt 2008;13(1):010502.
150. L Lim, N Rajaram, B Nichols, JW Tunnell. Time Resolved Study of Probe Pressure
Effects on Skin Fluorescence and Reflectance Spectroscopy Measurements. Biomedical
Optics OSA Technical Digest (CD). 2010;BTuD102.
151. Sarah Ruderman, Andrew J Gomes, Valentina Stoyneva, Jeremy D Rogers, Angela J
Fought, Borko D Jovanovic, Vadim Backman. Analysis of pressure, angle and temporal
effects on tissue optical properties from polarization-gated spectroscopic probe
measurements. Biomed Opt Express. 2010;1(2):489-499.
152. I. M. Greenberg. Self-retaining retractor and handrest system for
neurosurgery.Neurosurgery 1981;8(2):205-208.
153. J. W. Harding, I. N. Sneddon. Proc. Cambridge Philos. Soc. 1945;41:16.
154. Michael A. Green, Lynne E. Bilston, Ralph Sinkus. In vivo brain viscoelastic properties
measured by magnetic resonance elastography. NMR in Biomedicine. 2008;21(7):755–
764.
155.

S. Coyle, C. Markham, W. Lanigan, T. Ward. A Mechanical Mounting System for
Functional Near-Infrared Spectroscopy. Brain Imaging Studies Opto-Ireland 2005:
Optical Sensing and Spectroscopy.

156.

V. Chang, D. Merisier, B. Yu, D. Walmer, N. Ramanujam. Towards a field-compatible
optical spectroscopic device for cervical cancer screening in resource-limited settings:
effects of calibration and pressure. Optics Express 2011;19:17908-17924.

157.

H. Stefan, L.F. Quesney, B. Abou-Khalil, and A. Olivier, “Electrocorticography in
temporal lobe epilepsy surgery,” Acta Neurol Scand 83, 65–72 (1991)

158.

D.P. Sarco, J.F. Burke, and J.R. Madsen, “Electroencephalography in epilepsy surgery
planning,” Childs Nerv Syst. 22, 760-5 (2006)

159.

C. Juhász, D.C. Chugani, O. Muzik, C. Watson, J. Shah, A. Shah, and H.T. Chugani, “Is
epileptogenic cortex truly hypometabolic on interictal positron emission tomography?,”
Ann Neurol. 48, 88–96 (2000)

160.

H.T. Chugani, P.J. Rintahaka, and D.A. Shewmon, “Ictal patterns of cerebral glucose
utilization in children with epilepsy,” Epilepsia. 35, 813-22 (1994)

161.

Astrid Nehlig, “Cerebral metabolic and hemodynamic responses to epilepsy: insights
116

from animal models,” Future Neurology 1, 787-797 (2006)
162.

T. Huppert, S. Diamond, M. Franceschini, and D. Boas, “HomER: a review of time-series
analysis methods for near-infrared spectroscopy of the brain,” Appl. Opt. 48, D280-D298
(2009)

117

VITA
NITIN YADAV
Born, Alwar, India
2002

Bachelor of Engineering in Instrumentation Engineering
Sant Longowal Institute of Engineering & Technology
India

2004

Master of Technology in Biomedical Engineering
Indian Institute of Technology, Bombay
India

2006-2011

Graduate Assistant, Research Assistant
Department of Biomedical Engineering
Florida International University
Miami, Florida

2011-2012

Dissertation Year Fellow
University Graduate School
Florida International University
Miami, Florida

PUBLICATIONS
Nitin Yadav, Adrian Romero, Yinchen Song, Sanghoon Oh, John Ragheb, Sanjiv Bhatia, WeiChiang Lin, “Improving the quality of time-dependent, diffuse reflectance spectroscopic signals
measured from in vivo brain during craniotomy”, Revision Medical Engineering and Physics,
Apr. 2012
Nitin Yadav, Sanjiv Bhatia, John Ragheb, Rupal Mehta, Prasanna Jayakar, William Yong, WeiChiang Lin, “In Vivo Detection of Epileptic Brain Tissue Using Static Fluorescence and Diffuse
Reflectance Spectroscopy”, Revision Journal of Biomedical Optics, Aug. 2012
B. Zhu, N. Yadav, N. Patel, G. Rey, A. Godavarty, “Diffuse optical imaging of brain activation
to joint attention experience,” Neuroscience, Apr 2009

118

Nitin Yadav, Sanghoon Oh, Sanjiv Bhatia, Prasanna Jayakar, John Ragheb, Michael Duchowny,
Wei-Chiang Lin, “In vivo characterization of epileptic tissue with time-dependent, diffuse
reflectance spectroscopy”, The 26th Southern Biomedical Conference, April 30-May 2 2010,
College Park, MD
Romani Patel, Nitin Yadav, Dwayne McDaniel, David Roelant, "Gas Retention and Release Test
for Low Yield Stress Non-Newtonian Fluids "Waste Management Symposia, February 26-March
3, 2011, Phoenix, Arizona
R. Patel, N. Yadav, G. Tachiev, D. McDaniel, D. Roelant, “Gas Retention and Release Tests for
Low Yield Stress Non-Newtonian Fluids”, Environmental Management Waste Processing
Technical Exchange, November 16 - 18, 2010 Atlanta, Georgia
Romani Patel, Georgio Tachiev, Vishwani Sharma, Nitin Yadav, Dwayne McDaniel, David
Roelant, “Gas Retention and Release Experiments with Low Yield Stress Fluids” Waste
Management Symposia, March 7-11, 2010 , Phoenix, Arizona
Nitin Yadav, Banghe Zhu, Anuradha Godavarty, Gustavo Rey, “Joint-Attention Related Imaging
Studies using Optical Techniques”, Marino Autism Research Institute Scientific Symposium,
April 22, 2008, Vanderbuilt University, Nashville, Tennessee
Nitin Yadav, Banghe Zhu, Nirav Patel, Gustavo Rey, Anuradha Godavarty, “Joint attention
studies using Near Infrared Optical Imaging”, Biomedical Optics, March 16-19, 2008, OSA, St.
Petersburg, Florida
Banghe Zhu, Nitin Yadav, Nirav Patel, and A. Godavarty, “Functional brain mapping of joint
attention skills using diffuse optical imaging”, Biomedical Engineering Recent Development,
Eds: H. Nazeran, M. Goldman, R. Schoephoerster, 2008 Medical and Engineering Publishers,
Inc. 2008
Mita Bhowmick, Nitin Yadav, M.P. Thaddeus, Gargi Vishnoi, “Near-Infrared Light Propagation
in Scattering Tissue”, CIEE-2005- National Conference on Computational Intelligence in
Electrical Engineering, 18-19 Nov, 2005, Sant Longowal Institute of Engg. & Tech. (SLIET),
Sangrur, Punjab, India
Mita Bhowmick, Nitin Yadav, M.P. Thaddeus, Gargi Vishnoi, “Numerical Modeling of NearInfrared Light Propagation in Neonatal Head”, NCBME-2004- National conference on
biomedical Engineering, 23-24 Dec, 2004, GITAM, Visakhapatnam, Andhra Pradesh, India
Mita Bhowmick, Nitin Yadav, Gargi Vishnoi, “Numerical Modeling of Near-Infrared Light
Propagation in Tissue", Photonics-2004- Seventh International Conference on Optoelectronics,
Fiber Optics and Photonics, 9-11 Dec, 2004, Cochin, Kerela, India

119

